<SEC-DOCUMENT>0001140361-25-040186.txt : 20251103
<SEC-HEADER>0001140361-25-040186.hdr.sgml : 20251103
<ACCEPTANCE-DATETIME>20251103160453
ACCESSION NUMBER:		0001140361-25-040186
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		18
FILED AS OF DATE:		20251103
DATE AS OF CHANGE:		20251103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TORONTO DOMINION BANK
		CENTRAL INDEX KEY:			0000947263
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				135640479
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283969
		FILM NUMBER:		251444024

	BUSINESS ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
		BUSINESS PHONE:		416-944-6367

	MAIL ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ef20058088_424b2.htm
<DESCRIPTION>TERM SHEET
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <table cellspacing="0" cellpadding="2" border="0" style="font-size: 10pt; width: 100%; border-collapse: collapse;">

          <tr>
            <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 32.9%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 33%;"><br>
            </td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); vertical-align: top; width: 33%; font-size: 9pt; text-align: left;">
              <div style="text-align: right; font-family: Arial; font-size: 7pt; font-weight: bold;">Filed Pursuant to Rule 424(b)(2)</div>
              <div style="text-align: right; font-family: Arial; font-size: 7pt; font-weight: bold;">Registration Statement No. 333-283969</div>
              <div style="text-align: right; font-family: Arial; font-size: 7pt; font-weight: bold;">(To Prospectus dated February 26, 2025 </div>
              <div style="text-align: right; font-family: Arial; font-size: 7pt; font-weight: bold;">and Product Supplement EQUITY LIRN-1 dated March </div>
              <div style="text-align: right; font-family: Arial; font-size: 7pt; font-weight: bold;">3, 2025)</div>
            </td>
            <td colspan="1" style="border-bottom: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; font-size: 9pt; text-align: left;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc2188b63bb1049859338af4c92f4a6b3">

          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(31, 73, 125);">&#160;</td>
            <td colspan="2" style="vertical-align: top; background-color: rgb(31, 73, 125);">
              <div style="color: rgb(255, 255, 255);">595,103 Units</div>
              <div style="color: rgb(255, 255, 255);">$10 principal amount per unit</div>
              <div style="color: rgb(255, 255, 255);">CUSIP No. 89116N707</div>
            </td>
            <td style="width: 24%; vertical-align: top; background-color: rgb(31, 73, 125);">
              <div style="color: rgb(255, 255, 255);">Pricing Date</div>
              <div style="color: rgb(255, 255, 255);">Settlement Date</div>
              <div style="color: rgb(255, 255, 255);">Maturity Date</div>
            </td>
            <td style="width: 25%; vertical-align: top; background-color: rgb(31, 73, 125);">
              <div style="text-align: right; color: rgb(255, 255, 255);">October 30, 2025</div>
              <div style="text-align: right; color: rgb(255, 255, 255);">November 6, 2025</div>
              <div style="text-align: right; color: rgb(255, 255, 255);">December 28, 2026</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(31, 73, 125);">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(31, 73, 125);">&#160;</td>
            <td colspan="2" style="vertical-align: top; background-color: rgb(31, 73, 125);">
              <div><img width="58" height="52" src="image0.jpg"></div>
            </td>
            <td colspan="2" style="vertical-align: top; background-color: rgb(31, 73, 125);">&#160;</td>
            <td colspan="1" style="vertical-align: top; background-color: rgb(31, 73, 125); width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="background-color: #046E87; vertical-align: top; width: 1%; font-size: 2pt;">&#160;</td>
            <td style="background-color: #046E87; vertical-align: top; width: 25%; font-size: 2pt;"><br>
            </td>
            <td style="background-color: #C87D0E; vertical-align: top; width: 24%; font-size: 2pt;"><br>
            </td>
            <td style="background-color: #5C255C; vertical-align: top; width: 24%; font-size: 2pt;"><br>
            </td>
            <td style="background-color: #61961A; vertical-align: top; width: 25%; font-size: 2pt;"><br>
            </td>
            <td colspan="1" style="background-color: #61961A; vertical-align: top; width: 1%; font-size: 2pt;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(31, 73, 125);">&#160;</td>
            <td colspan="4" style="vertical-align: top; background-color: rgb(31, 73, 125);">
              <div style="color: rgb(255, 255, 255); font-size: 21pt; font-weight: bold;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF</div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="font-size: 8pt; color: #FFFFFF;">&#9726;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160; &#160; &#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">Maturity of approximately 14 months</font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="font-size: 8pt; color: #FFFFFF;">&#9726;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160; &#160; &#160;&#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">2-to-1 leveraged upside exposure to increases in the Underlying Fund, subject to a capped return of 17.81%</font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="font-size: 8pt; color: #FFFFFF;">&#9726;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">1-to-1 downside exposure to decreases in the Underlying Fund, with up to 100.00% of your principal at risk</font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="font-size: 8pt; color: #FFFFFF;">&#9726;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160; &#160; &#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">All payments occur at maturity and are subject to the credit risk of The Toronto-Dominion Bank</font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="font-size: 8pt; color: #FFFFFF;">&#9726;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">No periodic interest payments</font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="font-size: 8pt; color: #FFFFFF;">&#9726;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">In addition to the underwriting discount set forth below, the notes include a hedging-related charge of $0.05 per unit. See &#8220;Structuring the Notes&#8221;</font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="font-size: 8pt; color: #FFFFFF;">&#9726;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160; &#160; &#160;&#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">Limited secondary market liquidity, with no exchange listing</font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="font-size: 8pt; color: #FFFFFF;">&#9726;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">The notes are unsecured debt securities and are not savings accounts or insured deposits of TD. The notes are not insured or guaranteed by the Canada Deposit Insurance Corporation (the
                  &#8220;CDIC&#8221;), the U.S. Federal Deposit Insurance Corporation (the &#8220;FDIC&#8221;), or any other governmental agency of Canada, the United States or any other jurisdiction</font></div>
            </td>
            <td colspan="1" style="vertical-align: top; background-color: rgb(31, 73, 125); width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="background-color: #B8CCE4; vertical-align: top; width: 1%; font-size: 2pt;">&#160;</td>
            <td colspan="4" style="background-color: #B8CCE4; vertical-align: top; font-size: 2pt;">&#160;</td>
            <td colspan="1" style="background-color: #B8CCE4; vertical-align: top; width: 1%; font-size: 2pt;">&#160;</td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-size: 8pt; font-weight: bold;">The notes are being issued by The Toronto-Dominion Bank (&#8220;TD&#8221;). There are important differences between the notes and a conventional debt
        security, including different investment risks and certain additional costs. See &#8220;Risk Factors&#8221; beginning on page TS-6 of this term sheet, &#8220;Additional Risk Factors&#8221; on page TS-7 of this term sheet and &#8220;Risk Factors&#8221; beginning on page PS-7 of
        product supplement EQUITY LIRN-1 and page 1 of the prospectus.</div>
      <div style="margin: 0px 0px 3pt; font-size: 8pt;"><font style="font-weight: bold;">The initial estimated value of the notes at the time the terms of the notes were set on the pricing date was $9.886 per unit, which is less than the public offering
          price listed below.</font> See &#8220;Summary&#8221; on the following page, &#8220;Risk Factors&#8221; beginning on page TS-6 of this term sheet and &#8220;Structuring the Notes&#8221; on page TS-13 of this term sheet for additional information. The actual value of your notes at
        any time will reflect many factors and cannot be predicted with accuracy.</div>
      <div style="margin: 0px 0px 3pt; font-size: 8pt;"> <br>
      </div>
      <div style="font-size: 8pt; font-weight: bold; text-align: center;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 1px; width: 20%; color: #000000;"></div>
      <div style="margin: 0px 0px 3pt; font-size: 8pt; text-align: justify;">None of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;), any state securities commission, or any other regulatory body has approved or disapproved of these notes or passed
        upon the adequacy or accuracy of this document, product supplement EQUITY LIRN-1 or the prospectus. Any representation to the contrary is a criminal offense.</div>
      <div style="margin: 0px 0px 3pt; font-size: 8pt; text-align: justify;"> <br>
      </div>
      <div style="font-size: 8pt; font-weight: bold; text-align: center;">
        <hr noshade="noshade" align="center" style="height: 1px; width: 20%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z19eee10c0bc940a29c65e184c705f29b">

          <tr>
            <td style="width: 41.22%; vertical-align: top;"><br>
            </td>
            <td style="width: 26.06%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;"><u>Per Unit</u></div>
            </td>
            <td style="width: 32.72%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;"><u>Total</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.22%; vertical-align: top;">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">Public offering price</div>
            </td>
            <td style="width: 26.06%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">$10.000</div>
            </td>
            <td style="width: 32.72%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">$5,951,030.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.22%; vertical-align: top;">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">Underwriting discount</div>
            </td>
            <td style="width: 26.06%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">$0.175</div>
            </td>
            <td style="width: 32.72%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">$104,143.02</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.22%; vertical-align: top;">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">Proceeds, before expenses, to TD</div>
            </td>
            <td style="width: 26.06%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">$9.825</div>
            </td>
            <td style="width: 32.72%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">$5,846,886.98</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; text-indent: -46.35pt; margin-left: 46.35pt; margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">The notes:</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zda8715c3909b4a7b869688a0bec73a98">

          <tr>
            <td style="width: 33.17%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Are Not FDIC Insured</div>
            </td>
            <td style="width: 34.13%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Are Not Bank Guaranteed</div>
            </td>
            <td style="width: 32.7%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">May Lose Value</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: center;">
        <div style="margin-top: 5pt; font-size: 14pt; font-weight: bold;">BofA Securities</div>
        <div style="font-size: 10pt;">October 30, 2025</div>
        <div style="text-align: left;"> <br>
        </div>
        <div style="text-align: left;"> </div>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Summary</div>
      <div style="text-align: justify; margin-top: 5pt; font-size: 8pt;">The Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026 (the &#8220;notes&#8221;) are our senior unsecured debt
        securities, Series H. The notes are not guaranteed or insured by the CDIC, the FDIC or any other governmental agency, and are not, either directly or indirectly, an obligation of any third party. The notes are not bail-inable debt securities (as
        defined in the prospectus) under the CDIC Act.<font style="font-weight: bold;"> The notes will rank equally with all of our other senior unsecured debt. Any payments due on the notes, including any repayment of principal, will be subject to the
          credit risk of TD.</font> The notes provide you a leveraged return, subject to a cap, if the Ending Value of the Market Measure, which is the shares of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF (the &#8220;Underlying Fund&#8221;), is greater than
        the Starting Value. If the Ending Value is equal to the Starting Value, you will receive the principal amount of your notes. If the Ending Value is less than the Starting Value, you will lose all or a portion of the principal amount of your notes.
        Any payments on the notes will be calculated based on the $10 principal amount per unit and will depend on the performance of the Underlying Fund, subject to our credit risk. See &#8220;Terms of the Notes&#8221; below.</div>
      <div style="text-align: justify; margin-top: 5pt; font-size: 8pt;">The economic terms of the notes (including the Capped Value) are based on our internal funding rate (which is our internal borrowing rate based on variables such as market benchmarks
        and our appetite for borrowing) and several factors, including selling concessions, discounts, commissions or fees expected to be paid in connection with the offering of the notes, the estimated profit that we expect to earn in connection with
        structuring the notes, estimated costs which we may incur in connection with the notes and the economic terms of certain related hedging arrangements as discussed further below and under &#8220;Structuring the Notes&#8221; on page TS-13.</div>
      <div style="text-align: justify; margin-top: 5pt; font-size: 8pt;">On the cover page of this term sheet, we have provided the initial estimated value for the notes. The initial estimated value of your notes on the pricing date is less than their
        public offering price. The initial estimated value was determined by reference to our internal pricing models, which take into account a number of variables, typically including expected volatility of the Market Measure, interest rates (forecasted,
        current and historical rates), price-sensitivity analysis, time to maturity of the notes and our internal funding rate which take into account a number of variables and are based on a number of subjective assumptions, which are not evaluated or
        verified on an independent basis and may or may not materialize. Because our internal funding rate generally represents a discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding
        rate for the notes rather than the levels at which our benchmark debt securities trade in the secondary market is expected, assuming all other economic terms are held constant, to have increased the initial estimated value of the notes and to have
        had an adverse effect on the economic terms of the notes. For more information about the initial estimated value and the structuring of the notes, see the related discussion under &#8220;Risk Factors&#8221; and &#8220;Structuring the Notes&#8221; herein.</div>
      <div> <br>
      </div>
      <div class="BRPFTCL" style="float: left; width: 48%;">
        <div>
          <div>
            <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 18pt;">Terms of the Notes</div>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 25%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Issuer:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 73%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">The Toronto-Dominion Bank (&#8220;TD&#8221;)</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td nowrap="nowrap" style="width: 25%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Principal Amount:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 73%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">$10.00 per unit</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 25%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Term:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 73%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">Approximately 14 months</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 25%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Market Measure:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 73%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">The SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF (Bloomberg symbol: &#8220;FEZ&#8221;)</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 25%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Starting Value:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 73%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">$62.83</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 25%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Ending Value:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 73%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">The average of the Closing Market Price of the Market Measure multiplied by the Price Multiplier on each calculation day occurring during the
                    Maturity Valuation Period. The scheduled calculation days are subject to postponement in the event of Market Disruption Events, as described beginning on page PS-28 of product supplement EQUITY LIRN-1.</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 25%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Threshold Value:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 73%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">$62.83 (100.00% of the Starting Value).</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 25%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Price Multiplier:</div>
                  <div>&#160;</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 73%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">1, subject to adjustment for certain corporate events relating to the Underlying Fund, as described beginning on page PS-31 of product supplement
                    EQUITY LIRN-1.</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td nowrap="nowrap" style="width: 25%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin: 1.5pt 0px 0px; color: #5B862B; font-size: 7.5pt; font-weight: bold;">Participation </div>
                  <div style="margin: 0px 0px 1.5pt; color: #5B862B; font-size: 7.5pt; font-weight: bold;">Rate:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 73%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">200.00%</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 25%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Capped Value:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 73%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">$11.781 per unit, which represents a return of 17.81% over the principal amount.</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 25%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Maturity Valuation Period:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 73%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">December 16, 2026, December 17, 2026, December 18, 2026, December 21, 2026 and December 22, 2026</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td nowrap="nowrap" style="width: 25%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin: 1.5pt 0px 0px; color: #5B862B; font-size: 7.5pt; font-weight: bold;">Fees and </div>
                  <div style="margin: 0px 0px 1.5pt; color: #5B862B; font-size: 7.5pt; font-weight: bold;">Charges:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 73%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">The underwriting discount of $0.175 per unit listed on the cover page and the hedging related charge of $0.05 per unit described in &#8220;Structuring
                    the Notes&#8221; on page TS-13.</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td nowrap="nowrap" style="width: 25%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin: 1.5pt 0px 0px; color: #5B862B; font-size: 7.5pt; font-weight: bold;">Calculation</div>
                  <div style="margin: 0px 0px 1.5pt; color: #5B862B; font-size: 7.5pt; font-weight: bold;"> Agents:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 73%; vertical-align: top;">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">BofA Securities, Inc. (&#8220;BofAS&#8221;) and TD, acting jointly.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div class="BRPFTCR" style="float: right; width: 48%;">
        <div>
          <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">
            <div style="text-align: left; margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 18pt;">Redemption Amount Determination</div>
          </div>
          <div style="margin: 1.5pt 0px 9pt; font-size: 7.5pt; text-align: justify;">On the maturity date, you will receive a cash payment per unit determined as follows:</div>
          <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;"><img src="image00005.jpg"> </div>
        </div>
      </div>
      <div style="clear: both;"><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">2</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin-top: 3pt; margin-bottom: 3pt;">The terms and risks of the notes are contained in this term sheet and in the following:</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z52456488491b4f8589f7b0199c5e94d7">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: #5B8F22;">&#9726;</td>
            <td style="width: auto; vertical-align: top;">
              <div>Product supplement EQUITY LIRN-1 dated March 3, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 36pt; margin-top: 5pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006726/ef20044383_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006726/ef20044383_424b3.htm</a></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z765d942e3fd5480a9d279e5466f12d09">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: #5B8F22;">&#9726;</td>
            <td style="width: auto; vertical-align: top;">
              <div>Prospectus dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 36pt; margin-top: 5pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm">http://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm</a></div>
      <div style="text-align: justify; margin-top: 5pt;">These documents, including this term sheet (together, the &#8220;Note Prospectus&#8221;), have been filed as part of a registration statement with the SEC and may, without cost, be accessed on the SEC website as
        indicated above or obtained from Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated (&#8220;MLPF&amp;S&#8221;) or BofAS by calling 1-800-294-1322.</div>
      <div style="text-align: justify; margin-top: 5pt;">You should read the Note Prospectus, including this term sheet, for information about us and this offering. Any prior or contemporaneous oral statements and any other written materials you may have
        received are superseded by the Note Prospectus. Capitalized terms used but not defined in this term sheet have the meanings set forth in product supplement EQUITY LIRN-1. In the event of any conflict the following hierarchy will govern: first, this
        term sheet; second, product supplement EQUITY LIRN-1; and last, the prospectus. Unless otherwise indicated or unless the context requires otherwise, all references in this document to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or similar references are to TD.</div>
      <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Investor Considerations</div>
      <div class="BRPFTCL" style="float: left; width: 48%;">
        <div>
          <div style="font-weight: bold;">You may wish to consider an investment in the notes if:</div>
          <div style="font-weight: bold;">
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="z2d5dfbc4805d4c48bb4a9e13cc99fbd6" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #5B8F22;">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="text-align: justify;">You anticipate that the price of the Underlying Fund will increase moderately from the Starting Value to the Ending Value.</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="z22348354a67d44b88b4796779b9c062c" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #5B8F22;">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="text-align: justify;">You are willing to risk a substantial or entire loss of principal if the price of the Underlying Fund decreases from the Starting Value to the Ending Value.</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="zc2168d2e3f444ddc8e202262af58a957" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #5B8F22;">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;">You accept that the return on the notes will be capped.</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="z7736a8ea78c743b8924ca94f305fc1a8" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #5B8F22;">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="text-align: justify;">You are willing to forgo interest payments that are paid on conventional interest-bearing debt securities.</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="z8a0d746446224f60923578cf012dce13" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #5B8F22;">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="text-align: justify;">You are willing to forgo the benefits of directly owning the Underlying Fund or the securities held by the Underlying Fund, including dividends and other distributions.</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="z190c0d4e892d4878984b37476fff189e" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #5B8F22;">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="text-align: justify;">You are willing to accept that a limited market or no market exists for sales of the notes prior to maturity, and understand that the market price for the notes in any secondary market may be
                        adversely affected by various factors, including, but not limited to, our actual and perceived creditworthiness, our internal funding rate and fees and charges on the notes, as described on page TS-2.</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="z84f4ccdfe846497c8c1f534301acc922" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #5B8F22;">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="text-align: justify;">You are willing to assume our credit risk, as issuer of the notes, for all payments under the notes, including the Redemption Amount.</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div class="BRPFTCR" style="float: right; width: 48%;">
        <div>
          <div style="font-weight: bold;">The notes may not be an appropriate investment for you if:</div>
          <div style="font-weight: bold;">
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="z583b8556f05949bdb677872a23f6e457" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #5B8F22;">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="text-align: justify;">You believe that the price of the Underlying Fund will decrease from the Starting Value to the Ending Value or that it will not increase sufficiently over the term of the notes to provide you with
                        your desired return.</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="font-weight: bold;">
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="z1eb1281cda574150af71db41280a1950" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;"><font style="color: rgb(91, 143, 34);">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="text-align: justify;">You seek principal repayment or preservation of capital.</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="z417b29a20e0f4c0489d64b7b9193d94b" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #5B8F22;">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="text-align: justify;">You seek an uncapped return on your investment.</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="z0db755e3f7c544bfbdb8b68208541f96" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="text-align: justify; text-indent: -18pt; margin-left: 18pt; margin-top: 5pt;"><font style="color: #5B8F22;">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="text-align: justify;">You seek interest payments or other current income on your investment.</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="z434d0824702d4e8dbf77059f1457c257" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #5B8F22;">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="text-align: justify;">You want to receive the benefits of directly owning the Underlying Fund or the securities held by the Underlying Fund, including dividends and other distributions.</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="zd591fc16a1bc4e7985314c874d8c4374" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #5B8F22;">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="text-align: justify;">You seek an investment for which there will be a liquid secondary market.</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" id="z08dd5173c05b40a09bbc56eea793dcac" style="margin: 5pt 0px 0px; width: 100%; font-family: Arial; font-size: 9pt;">

                  <tr style="vertical-align: top;">
                    <td style="text-align: right; vertical-align: top; width: 9pt;">
                      <div style="margin: 0px 0px 0px 18pt; text-align: justify; text-indent: -18pt;"><font style="color: #5B8F22;">&#9726;</font></div>
                    </td>
                    <td style="text-align: left; vertical-align: top; width: auto;">
                      <div style="text-align: justify;">You are unwilling or are unable to take market risk on the notes or to accept the credit risk of TD as issuer of the notes.</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="clear: both;"><br>
      </div>
      <div>We urge you to consult your investment, legal, tax, accounting, and other advisors concerning an investment in the notes.<br>
        <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">3</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin-top: 5pt; color: rgb(91, 134, 43); font-size: 20pt;">Hypothetical Payout Profile</div>
      <div class="BRPFTCL" style="float: left; width: 48%;">
        <div>
          <div style="margin: 0px 0px 6pt; font-weight: bold; text-align: center;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
          <div style="margin: 0px 0px 0px; font-weight: bold; text-align: center;"><img src="image00006.jpg"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"> </sup></div>
        </div>
      </div>
      <div class="BRPFTCR" style="float: right; width: 48%;">
        <div>
          <div style="margin: 0px 0px 6pt; text-align: justify;">This graph reflects the returns on the notes, based on the Participation Rate of 200.00%, the Threshold Value of 100.00% of the Starting Value and the Capped Value of $11.781 per unit. The
            green line reflects the returns on the notes, while the dotted gray line reflects the returns of a direct investment in the Market Measure, excluding dividends or distributions.</div>
          <div style="text-align: justify; margin-top: 5pt; margin-bottom: 6pt;">This graph has been prepared for purposes of illustration only. See the below table for a further illustration of the range of hypothetical payments at maturity.</div>
        </div>
      </div>
      <div style="clear: both;"><br>
      </div>
      <div style="text-align: justify; color: rgb(91, 134, 43); font-size: 20pt;">Hypothetical Payments at Maturity</div>
      <div style="text-align: justify; margin-top: 6pt;">The following table and examples are for purposes of illustration only. They are based on <font style="font-weight: bold;">hypothetical</font> values and show <font style="font-weight: bold;">hypothetical</font>
        returns on the notes. They illustrate the calculation of the Redemption Amount and total rate of return based on a hypothetical Starting Value of 100.00, a hypothetical Threshold Value of 100.00, the Participation Rate of 200.00%, the Capped Value
        of $11.781 per unit and a range of hypothetical Ending Values. <font style="font-weight: bold;">The actual amount you receive and the resulting total rate of return will depend on the actual Starting Value, Threshold Value, and Ending Value and
          whether you hold the notes to maturity.</font> The following examples do not take into account any tax consequences from investing in the notes.</div>
      <div style="text-align: justify; margin-top: 5pt; margin-bottom: 5pt;">For recent actual prices of the Underlying Fund, see &#8220;The Underlying Fund&#8221; section below. In addition, all payments on the notes are subject to issuer credit risk. If TD, as
        issuer, becomes unable to meet its obligations as they become due, you could lose some or all of your investment.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1848a12450de42c185bcd4878cf548e0">

          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center; font-weight: bold;">Ending Value</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center; font-weight: bold;">Percentage Change </div>
              <div style="text-align: center; font-weight: bold;">from the Starting Value </div>
              <div style="text-align: center; font-weight: bold;">to the Ending Value</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center; font-weight: bold;">Redemption Amount </div>
              <div style="text-align: center; font-weight: bold;">per Unit</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center; font-weight: bold;">Total Rate of Return on </div>
              <div style="text-align: center; font-weight: bold;">the Notes</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">0.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">-100.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$0.000</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">-100.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">25.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">-75.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$2.500</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">-75.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">50.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">-50.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$5.000</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">-50.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">60.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">-40.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$6.000</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">-40.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">70.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">-30.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$7.000</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">-30.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">80.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">-20.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$8.000</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">-20.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">90.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">-10.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$9.000</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">-10.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">95.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">-5.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$9.500</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">-5.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">&#160;&#160;&#160;&#160;&#160;&#160;100.00<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(2)</sup></div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">0.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$10.000</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">0.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">102.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">2.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$10.400</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">4.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">104.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">4.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$10.800</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">8.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">106.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">6.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$11.200</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">12.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">108.91</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">8.91%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$11.781</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">17.81%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">110.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">10.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$11.781</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">17.81%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">120.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">20.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$11.781</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">17.81%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">130.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">30.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$11.781</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">17.81%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">140.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">40.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$11.781</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">17.81%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36.87%; vertical-align: bottom;">
              <div style="text-align: center;">150.00</div>
            </td>
            <td style="width: 21.05%; vertical-align: bottom;">
              <div style="text-align: center;">50.00%</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">$11.781</div>
            </td>
            <td style="width: 21.04%; vertical-align: bottom;">
              <div style="text-align: center;">17.81%</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z77d4218004294471bf01aae05e174279">

          <tr>
            <td style="width: 27pt; vertical-align: top;">(1)</td>
            <td style="width: auto; vertical-align: top;">
              <div>This is the <font style="font-weight: bold;">hypothetical</font> Threshold Value.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z78bd5398875643d491eca7c88e2fcb84">

          <tr>
            <td style="width: 27pt; vertical-align: top;">(2)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The <font style="font-weight: bold;">hypothetical</font> Starting Value of 100.00 used in these examples has been chosen for illustrative purposes only. The actual Starting Value is $62.83, which was the Closing Market Price of the
                Underlying Fund on the pricing date.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="zb3bd8d05e8ea4ceda6a9dd98c1f735ef">

          <tr>
            <td style="width: 27pt; vertical-align: top;">(3)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Redemption Amount per unit cannot exceed the<font style="font-weight: bold;">&#160;</font>Capped Value.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">4</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin-top: 5pt; margin-bottom: 5pt; font-weight: bold;">Redemption Amount Calculation Examples</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1820175a67bc410bb7234e5f310d9251">

          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">Example 1</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-top: 5pt;">The Ending Value is 60.00, or 60.00% of the Starting Value:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 13%; vertical-align: bottom;">
              <div style="margin-top: 5pt;">Starting Value:</div>
            </td>
            <td style="width: 87%; vertical-align: middle;">100.00</td>
          </tr>
          <tr>
            <td style="width: 13%; vertical-align: top;">
              <div style="margin-top: 5pt;">Threshold Value:</div>
            </td>
            <td style="width: 87%; vertical-align: middle;">100.00</td>
          </tr>
          <tr>
            <td style="width: 13%; vertical-align: top;">
              <div style="margin-top: 5pt;">Ending Value:</div>
            </td>
            <td style="width: 87%; vertical-align: middle;">60.00</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 32%; vertical-align: top;">
              <div style="text-align: center;"><img width="140" height="34" src="image1.jpg"></div>
            </td>
            <td style="width: 68%; vertical-align: middle;">
              <div><font style="font-weight: bold;">= $6.00</font> Redemption Amount per unit</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">Example 2</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-top: 5pt;">The Ending Value is 102.00, or 102.00% of the Starting Value:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 13%; vertical-align: top;">
              <div style="margin-top: 5pt;">Starting Value:<font style="text-indent: 0px; font-size: 5.14pt;" class="TRGRRTFtoHTMLTab"><br>
                </font></div>
            </td>
            <td style="width: 87%; vertical-align: bottom;">100.00</td>
          </tr>
          <tr>
            <td style="width: 13%; vertical-align: top;">
              <div style="margin-top: 5pt;">Ending Value:</div>
            </td>
            <td style="width: 87%; vertical-align: bottom;">102.00</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 32%; vertical-align: top;">
              <div style="text-align: center;">&#160;<img width="212" height="34" src="image2.jpg"></div>
            </td>
            <td style="width: 68%; vertical-align: middle;">
              <div><font style="font-weight: bold;">= $10.40 </font>Redemption Amount per unit</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">Example 3</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-top: 5pt;">The Ending Value is 130.00, or 130.00% of the Starting Value:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 13%; vertical-align: top;">
              <div style="margin-top: 5pt;">Starting Value:</div>
            </td>
            <td style="width: 87%; vertical-align: bottom;">100.00</td>
          </tr>
          <tr>
            <td style="width: 13%; vertical-align: top;">
              <div style="margin-top: 5pt;">Ending Value:<font style="text-indent: 0px; font-size: 5.14pt;" class="TRGRRTFtoHTMLTab"><br>
                </font></div>
            </td>
            <td style="width: 87%; vertical-align: bottom;">130.00</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 32%; vertical-align: top;">
              <div style="text-align: center;"><img width="212" height="34" src="image3.jpg"></div>
            </td>
            <td style="width: 68%; vertical-align: middle;">
              <div style="font-weight: bold; text-align: justify;">= $16.00, however, because the Redemption Amount for the notes cannot exceed the Capped Value, the Redemption Amount will be $11.781 per unit</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">5</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Risk Factors</div>
      <div style="text-align: justify; margin-top: 5pt; font-style: italic;">There are important differences between the notes and a conventional debt security. An investment in the notes involves significant risks, including those listed below. You should
        carefully review the more detailed explanation of risks relating to the notes in the &#8220;Risk Factors&#8221; sections beginning on page PS-7 of product supplement EQUITY LIRN-1 and page 1 of the prospectus. We also urge you to consult your investment,
        legal, tax, accounting, and other advisors as to the risks entailed by an investment in the notes and the suitability of the notes in light of your particular circumstances.</div>
      <div style="margin-top: 5pt; font-weight: bold;"><u>Structure-Related Risks</u></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z2f7ba25569a9474ab735a9122007964b">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Depending on the performance of the Underlying Fund as measured shortly before the maturity date, your investment may result in a loss; there is no guaranteed return of principal.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z21f8fcfd284b41569dacecdafd0dc5c9">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Your return on the notes may be less than the yield you could earn by owning a conventional fixed or floating rate debt security of comparable maturity.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="za3eb1430c44240f0b4cabb8d82723e3b">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Your investment return is limited to the return represented by the Capped Value and may be less than a comparable investment directly in the Underlying Fund or the securities held by the Underlying Fund.</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; font-weight: bold;"><u>Market Measure-Related Risks</u></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z5a2da94b62014fe5bd4cea3550700432">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The sponsor and investment advisor of the Underlying Fund may adjust the Underlying Fund in a way that may adversely affect the value of the notes and the amount payable on the notes, and these entities have no obligation to consider
                your interests.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z3fa571ebc691482f8d93fba0e1d8209d">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The sponsor of the EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (the &#8220;Underlying Index&#8221;), described below, may adjust the Underlying Index in a way that affects its level, and has no obligation to consider your interests.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="zfa156aa9cca0493682bddd72e8245b9c">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You will have no rights of a holder of the Underlying Fund or the securities held by the Underlying Fund, and you will not be entitled to receive any shares of the Underlying Fund or the securities held by the Underlying Fund, or any
                dividends or other distributions in respect of the Underlying Fund or the securities held by the Underlying Fund.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z5c36ba06ec394399a3051f5f8181babc">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>While we, MLPF&amp;S, BofAS or our or their respective affiliates may from time to time own shares of the Underlying Fund or the securities held by the Underlying Fund, none of us, MLPF&amp;S, BofAS or our or their respective affiliates
                control the Underlying Fund or any company held by the Underlying Fund, and have not verified any disclosure made by the Underlying Fund or any other company.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="zffc0e2943d734fa7a2cc840de61eba2c">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>There are liquidity and management risks associated with the Underlying Fund.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z7cdbc643013745df8f74214fdde0f27d">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The performance of the Underlying Fund may not correlate with the performance of its Underlying Index as well as the net asset value per share of the Underlying Fund, especially during periods of market volatility when the liquidity and
                the market price of the shares of the Underlying Fund and/or the securities held by the Underlying Fund may be adversely affected, sometimes materially.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="za6c5be74564f4c8984844cd0f530bf8c">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Redemption Amount will not be adjusted for all corporate events that could affect the Underlying Fund. See &#8220;Description of LIRNs&#8212;Anti-Dilution and Discontinuance Adjustments Relating to Underlying Funds&#8221; beginning on page PS-31 of
                product supplement EQUITY LIRN-1.</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; font-weight: bold;"><u>Valuation- and Market-Related Risks</u></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="zc8dacc603c994496bd45902164e115ca">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #76923C;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The initial estimated value of your notes on the pricing date is less than their public offering price. The difference between the public offering price of your notes and the initial estimated value of the notes reflects costs and
                expected profits associated with selling and structuring the notes, as well as hedging our obligations under the notes (including, but not limited to, the hedging related charge, as further described under &#8220;Structuring the Notes&#8221; on page
                TS-13). Because hedging our obligations entails risks and may be influenced by market forces beyond our control, this hedging may result in a profit that is more or less than expected, or a loss and the amount of any such profit or loss
                will not be known until the maturity date.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="za6c692eca337444495fe64ddab3f5227">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #76923C;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The initial estimated value of your notes is based on our internal funding rate. The internal funding rate used in the determination of the initial estimated value of the notes generally represents a discount from the credit spreads for
                our conventional fixed-rate debt securities and the borrowing rate we would pay for our conventional fixed-rate debt securities. This discount is based on, among other things, our view of the funding value of the notes as well as the higher
                issuance, operational and ongoing liability management costs of the notes in comparison to those costs for our conventional fixed-rate debt, as well as estimated financing costs of any hedge positions (including, but not limited to, the
                hedging related charge, as further described under &#8220;Structuring the Notes&#8221; on page TS-13), taking into account regulatory and internal requirements. If the interest rate implied by the credit spreads for our conventional fixed-rate debt
                securities, or the borrowing rate we would pay for our conventional fixed-rate debt securities were to be used, we would expect the economic terms of the notes to be more favorable to you. Additionally, assuming all other economic terms are
                held constant, the use of an internal funding rate for the notes is expected to have increased the initial estimated value of the notes and have had an adverse effect on the economic terms of the notes.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="za3a9d45a0461417cab05a79fdb62ed46">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #76923C;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The initial estimated value of the notes is based on our internal pricing models, which may prove to be inaccurate and may be different from the pricing models of other financial institutions, including BofAS and MLPF&amp;S. The initial
                estimated value of your notes when the terms of the notes were set on the pricing date is based on our internal pricing models, which take into account a number of variables, typically including the expected volatility of the Market
                Measure, interest rates (forecasted, current and</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">6</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 0pt; margin-left: 36pt; margin-top: 5pt;">historical rates), price-sensitivity analysis, time to maturity of the notes and our internal funding rate, and are based on a number of subjective assumptions,
        which are not evaluated or verified on an independent basis and may or may not materialize. Further, our pricing models may be different from other financial institutions&#8217; pricing models, including those of BofAS and MLPF&amp;S, and the
        methodologies used by us to estimate the value of the notes may not be consistent with those of other financial institutions that may be purchasers or sellers of notes in any secondary market. As a result, the secondary market price of your notes,
        if any, may be materially less than the initial estimated value of the notes determined by reference to our internal pricing models. In addition, market conditions and other relevant factors in the future may change and any assumptions may prove to
        be incorrect.</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z4b18f05da93e496393a2e42f94acacdf">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #76923C;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The initial estimated value of your notes is not a prediction of the prices at which you may sell your notes in the secondary market, if any exists, and such secondary market prices, if any, will likely be less than the public offering
                price of your notes, may be less than the initial estimated value of your notes and could result in a substantial loss to you. The initial estimated value of the notes will not be a prediction of the prices at which MLPF&amp;S, BofAS, or
                our or their respective affiliates or third parties may be willing to purchase the notes from you in secondary market transactions (if they are willing to purchase, which they are not obligated to do). The price at which you may be able to
                sell your notes in the secondary market at any time, if any, will be influenced by many factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than the
                initial estimated value of the notes. Further, as secondary market prices of your notes take into account the levels at which our debt securities trade in the secondary market, and do not take into account our various costs and expected
                profits associated with selling and structuring the notes, as well as hedging our obligations under the notes, secondary market prices of your notes will likely be less than the public offering price of your notes. As a result, the price at
                which MLPF&amp;S, BofAS, or our or their respective affiliates or third parties may be willing to purchase the notes from you in secondary market transactions, if any, will likely be less than the price you paid for your notes, and any sale
                prior to maturity could result in a substantial loss to you.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="zc3ed7973116349dc904061459f854c5e">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #76923C;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>A trading market is not expected to develop for the notes. None of us, MLPF&amp;S, BofAS or our or their respective affiliates is obligated to make a market for, or to repurchase, the notes. There is no assurance that any party will be
                willing to purchase your notes at any price in any secondary market.</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; font-weight: bold;"><u>Conflict-Related Risks</u></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z2f6c923649324dd19f8cf19ded9eb824">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Our business, hedging and trading activities, and those of MLPF&amp;S, BofAS and our and their respective affiliates (including trades in the Underlying Fund or the securities held by the Underlying Fund), and any hedging and trading
                activities we, MLPF&amp;S, BofAS or our or their respective affiliates engage in for our clients&#8217; accounts, may affect the market value of, and return on, the notes and may create conflicts of interest with you.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z7672ac80c95f4bc382aaa6ce5f79a769">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>There may be potential conflicts of interest involving the calculation agents, one of which is us and one of which is BofAS, as the determinations made by the calculation agents may be discretionary and could adversely affect any payment
                on the notes.</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; font-weight: bold;"><u>General Credit-Related Risks</u></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="zf852a5408d9747c09c1709ec153b9fb0">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Payments on the notes are subject to our credit risk, and actual or perceived changes in our creditworthiness are expected to affect the value of the notes. If we become unable to meet our financial obligations as they become due, you
                may lose some or all of your investment.</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; font-weight: bold;"><u>Tax-Related Risks</u></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="z3e018696a86f42c0ba496ef3aa60194e">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The U.S. federal income tax consequences of the notes are uncertain and, because of this uncertainty, there is a risk that the U.S. federal income tax consequences of the notes could differ materially and adversely from the treatment
                described below in &#8220;Supplemental Discussion of U.S. Federal Income Tax Consequences&#8221;, as described further in product supplement EQUITY LIRN-1 under &#8220;Material U.S. Federal Income Tax Consequences &#8212; Alternative Treatments&#8221;. You should
                consult your tax advisors as to the tax consequences of an investment in the notes and the potential alternative treatments.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 5pt;" class="DSPFListTable" id="zcf94b3ae87f1439e88c26dfabfcf7465">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #5B862B;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>For a discussion of the Canadian federal income tax consequences of investing in the notes, please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; and in the product supplement EQUITY LIRN-1 under
                &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221; and the further discussion herein under &#8220;Summary of Canadian Federal Income Tax Consequences&#8221;. If you are not a Non-resident Holder (as that term is defined in the prospectus) for
                Canadian federal income tax purposes or if you acquire the notes in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the notes and receiving the payments that might be
                due under the notes.</div>
            </td>
          </tr>

      </table>
      <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Additional Risk Factors</div>
      <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">The notes are subject to foreign currency exchange rate risk.</div>
      <div style="text-align: justify; margin-top: 5pt;">&#160;The Underlying Fund holds securities traded outside of the United States. The Underlying Fund&#8217;s share price will fluctuate based upon its net asset value, which will in turn depend in part upon
        changes in the value of the currencies in which the securities held by the Underlying Fund are traded. Accordingly, investors in the notes will be exposed to currency exchange rate risk with respect to each of the currencies in which the securities
        held by the Underlying Fund are traded. An investor&#8217;s net exposure will depend on the extent to which these currencies strengthen or weaken against the U.S. dollar. If the dollar strengthens against these currencies, the net asset value of the
        Underlying Fund will be adversely affected and the price of the Underlying Fund may decrease.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">7</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">The notes are subject to risks associated with foreign securities markets.</div>
      <div style="text-align: justify; margin-top: 5pt;">&#160;The Underlying Fund includes certain foreign equity securities. You should be aware that investments in securities linked to the value of foreign equity securities involve particular risks. The
        foreign securities markets comprising the Underlying Fund may have less liquidity and may be more volatile than U.S. or other securities markets and market developments may affect foreign markets differently from U.S. or other securities markets.
        Direct or indirect government intervention to stabilize these foreign securities markets, as well as cross-shareholdings in foreign companies, may affect trading prices and volumes in these markets. Also, there is generally less publicly available
        information about foreign companies than about those U.S. companies that are subject to the reporting requirements of the SEC, and foreign companies are subject to accounting, auditing and financial reporting standards and requirements that differ
        from those applicable to U.S. reporting companies.</div>
      <div style="text-align: justify; margin-top: 5pt;">Prices of securities in foreign countries are subject to political, economic, financial and social factors that apply in those geographical regions. These factors, which could negatively affect those
        securities markets, include the possibility of recent or future changes in a foreign government&#8217;s economic and fiscal policies, the possible imposition of, or changes in, currency exchange laws or other laws or restrictions applicable to foreign
        companies or investments in foreign equity securities and the possibility of fluctuations in the rate of exchange between currencies, the possibility of outbreaks of hostility and political instability and the possibility of natural disaster or
        adverse public health developments in the region. Moreover, foreign economies may differ favorably or unfavorably from the U.S. economy in important respects such as growth of gross national product, rate of inflation, capital reinvestment,
        resources and self-sufficiency.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">8</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">The Underlying Fund</div>
      <div style="text-align: justify; margin-top: 5pt;">All disclosures contained in this term sheet regarding the Underlying Fund, including, without limitation, its make-up, method of calculation, and changes in its components, have been derived from
        publicly available sources. The information reflects the policies of, and is subject to change by, SSGA Funds Management, Inc., the advisor to the Underlying Fund (the &#8220;sponsor&#8221; or &#8220;SSGA&#8221;). The sponsor has no obligation to continue to publish, and
        may discontinue publication of, the Underlying Fund. The consequences of the sponsor discontinuing publication of the Underlying Fund are discussed in the section entitled &#8220;Description of LIRNs &#8212;Anti-Dilution and Discontinuance Adjustments Relating
        to Underlying Funds&#8221; beginning on page PS-31 of product supplement EQUITY LIRN-1. None of us, our affiliates, the calculation agents, MLPF&amp;S or BofAS accepts any responsibility for the calculation, maintenance or publication of the Underlying
        Fund or any successor Underlying Fund.</div>
      <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">The SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF</div>
      <div style="text-align: justify; margin-top: 5pt;">&#160;<font style="color: rgb(0, 0, 0);">The Underlying Fund seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> Index. The FEZ Fund is an exchange-traded fund that trades on the NYSE Arca, Inc. under the ticker symbol &#8220;FEZ.&#8221;</font></div>
      <div style="text-align: justify; margin-top: 5pt;"><font style="color: rgb(0, 0, 0);">In seeking to track the performance of the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> Index, the FEZ employs a
          sampling strategy, which means that the FEZ is not required to purchase all of the securities represented in the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> Index. Instead, the FEZ may purchase a
          subset of the securities in the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> Index in an effort to hold a portfolio of securities with generally the same risk and return characteristics of the EURO </font>STOXX<font style="color: rgb(0, 0, 0);"> 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> Index. The quantity of holdings in the FEZ Fund will be based on a number of factors, including asset size of the FEZ. Based on its
          analysis of these factors, SSGA FM, either may invest the FEZ&#8217;s assets in a subset of securities in underlying index or may invest the FEZ&#8217;s assets in substantially all of the securities represented in the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> Index in approximately the same proportions as the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> Index.</font></div>
      <div style="text-align: justify; margin-top: 5pt;"><font style="color: rgb(0, 0, 0);">While SSGA FM seeks to track the performance of the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174; </sup><font style="color: rgb(0, 0, 0);">Index (</font><font style="font-style: italic; color: rgb(0, 0, 0);">i.e.</font><font style="color: rgb(0, 0, 0);">, achieve a high degree of correlation with the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> Index), the
        </font>FEZ&#8217;s<font style="color: rgb(0, 0, 0);"> return may not match the return of the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> Index. The FEZ incurs a number of operating expenses not applicable
          to the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174; </sup><font style="color: rgb(0, 0, 0);">Index, and incurs costs in buying and selling securities. In addition, the FEZ may not be fully invested at times, generally as a result of cash
          flows into or out of the FEZ or reserves of cash held by the FEZ to meet redemptions. SSGA FM may attempt to replicate the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> Index return by investing in
          fewer than all of the securities in the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174; </sup><font style="color: rgb(0, 0, 0);">Index, or in some securities not included in the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> Index, potentially increasing the risk of divergence between the FEZ&#8217;s return and that of the EURO STOXX 50</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);"> Index.</font></div>
      <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">The EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174; </sup>Index</div>
      <div style="text-align: justify; margin-top: 5pt;">The Euro STOXX 50 Index (&#8220;SX5E&#8221;) is a capitalization-weighted index of 50 European blue-chip stocks in 11 Eurozone countries. Publication of the SX5E began on February 26, 1998, based on an initial
        index value of 1,000 at December 31, 1991. The level of the SX5E is disseminated on, and additional information about the SX5E is published on, the STOXX website. Information contained in the STOXX website is not incorporated by reference in, and
        should not be considered a part of, this term sheet.</div>
      <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">Index Composition and Maintenance</div>
      <div style="text-align: justify; margin-top: 5pt;">The SX5E is composed of 50 stocks from 11 Eurozone countries (Austria, Belgium, Finland, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, Portugal and Spain) of the STOXX Europe 600
        Supersector indices. The STOXX 600 Supersector indices contain the 600 largest stocks traded on the major exchanges of 18 European countries and are organized into the following 20 Supersectors: automobiles &amp; parts; banks; basic resources;
        chemicals; construction &amp; materials; consumer products &amp; services; energy; financial services; food, beverages &amp; tobacco; health care; industrial goods &amp; services; insurance; media; personal care, drug &amp; grocery stores; real
        estate; retailers; technology; telecommunications; travel &amp; leisure; and utilities.</div>
      <div style="text-align: justify; margin-top: 5pt;">For each of the 20 EURO STOXX regional supersector indices, the stocks are ranked in terms of free-float market capitalization. The largest stocks are added to the selection list until the coverage
        is close to, but still less than, 60% of the free-float market capitalization of the corresponding supersector index. If the next highest-ranked stock brings the coverage closer to 60% in absolute terms, then it is also added to the selection list.
        All current stocks in the SX5E are then added to the selection list. All of the stocks on the selection list are then ranked in terms of free-float market capitalization to produce the final index selection list. The largest 40 stocks on the
        selection list are selected; the remaining 10 stocks are selected from the largest remaining current stocks ranked between 41 and 60; if the number of stocks selected is still below 50, then the largest remaining stocks are selected until there are
        50 stocks. In exceptional cases, STOXX&#8217;s management board can add stocks to and remove them from the selection list.</div>
      <div style="text-align: justify; text-indent: 18pt; margin-top: 5pt;">The SX5E components are subject to a capped maximum index weight of 10%, which is applied on a quarterly basis.</div>
      <div style="text-align: justify; text-indent: 18pt; margin-top: 5pt;">The composition of the SX5E is reviewed annually, based on the closing stock data on the last trading day in August. Changes in the composition of the SX5E are made to ensure that
        the SX5E includes the 50 market sector leaders from within the SX5E.</div>
      <div style="text-align: justify; text-indent: 18pt; margin-top: 5pt;">The free float factors for each component stock used to calculate the SX5E, as described below, are reviewed, calculated, and implemented on a quarterly basis and are fixed until
        the next quarterly review.</div>
      <div style="text-align: justify; text-indent: 18pt; margin-top: 5pt;">The SX5E is subject to a &#8220;fast exit rule.&#8221; The SX5E components are monitored for any changes based on the monthly selection list ranking. A stock is deleted from the SX5E if: (a)
        it ranks 75 or below on the monthly selection list and (b) it has been ranked 75 or below for a consecutive period of two months in the monthly selection list. The highest-ranked stock that is not an SX5E component will replace it. Changes will be
        implemented on the close of the fifth trading day of the month, and are effective the next trading day.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">9</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 18pt; margin-top: 5pt;">The SX5E is also subject to a &#8220;fast entry rule.&#8221; All stocks on the latest selection lists and initial public offering (IPO) stocks are reviewed for a fast-track addition on a
        quarterly basis. A stock is added, if (a) it qualifies for the latest STOXX blue-chip selection list generated at the end of February, May, August or November and (b) it ranks within the &#8220;lower buffer&#8221; (ranks 1-25) on this selection list.</div>
      <div style="text-align: justify; text-indent: 18pt; margin-top: 5pt;">The SX5E is also reviewed on an ongoing monthly basis. Corporate actions (including initial public offerings, mergers and takeovers, spin-offs, delistings, and bankruptcy) that
        affect the SX5E composition are announced immediately, implemented two trading days later and become effective on the next trading day after implementation.</div>
      <div style="text-align: justify; margin-top: 5pt; font-style: italic;">Index Calculation</div>
      <div style="text-align: justify; text-indent: 18pt; margin-top: 5pt;">The SX5E is calculated with the &#8220;Laspeyres formula,&#8221; which measures the aggregate price changes in the component stocks against a fixed base quantity weight. The formula for
        calculating the Index value can be expressed as follows:</div>
      <div style="text-align: center; margin-top: 5pt;">Index = <u>free float market capitalization of the Index at the time</u></div>
      <div style="text-align: center; margin-top: 5pt;">divisor of the Index at the time</div>
      <div style="text-align: justify; text-indent: 18pt; margin-top: 5pt;">The &#8220;free float market capitalization of the Index&#8221; is equal to the sum of the products of the closing price, number of shares, free float factor, and weighting cap factor for the
        component company as of the time that the SX5E is being calculated.</div>
      <div style="text-align: justify; text-indent: 18pt; margin-top: 5pt;">The SX5E is also subject to a divisor, which is adjusted to maintain the continuity of the index values across changes due to corporate actions, such as the deletion and addition
        of stocks, the substitution of stocks, stock dividends, and stock splits.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">10</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">Historical Data</div>
      <div style="text-align: justify; margin-top: 5pt; font-style: italic; font-weight: bold;">The following graph shows the daily historical performance of the Underlying Fund on its primary exchange in the period from January 1, 2015 through October 30,
        2025. We obtained this historical data from Bloomberg L.P. We have not independently verified the accuracy or completeness of the information obtained from Bloomberg L.P. On the pricing date, the Closing Market Price of the Underlying Fund was
        $62.83. The graph below may have been adjusted to reflect certain corporate actions such as stock splits and reverse stock splits.</div>
      <div style="text-align: center; margin-top: 5pt; font-weight: bold;">Historical Performance of the Underlying Fund</div>
      <div style="margin-top: 5pt; text-align: center;"><img src="image00004.jpg"></div>
      <div style="text-align: justify; margin-top: 5pt; font-style: italic; font-weight: bold;">This historical data on the Underlying Fund is not necessarily indicative of the future performance of the Underlying Fund or what the value of the notes may
        be. Any historical upward or downward trend in the price per share of the Underlying Fund during any period set forth above is not an indication that the price per share of the Underlying Fund is more or less likely to increase or decrease at any
        time over the term of the notes.</div>
      <div style="text-align: justify; margin-top: 5pt;">You should consult publicly available sources for the prices and trading patterns of the Underlying Fund.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">11</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Supplement to the Plan of Distribution (Conflicts of Interest)</div>
      <div style="text-align: justify; margin-top: 5pt; margin-bottom: 5pt;">Under our distribution agreement, we have appointed TDS, an affiliate of TD, and BofAS as agents for the sale of the notes. TDS will purchase the notes from us, and BofAS will
        purchase the notes from TDS, each at the public offering price less the indicated underwriting discount indicated on the cover hereof MLPF&amp;S will purchase the notes from BofAS for resale, and will receive a selling concession in connection with
        the sale of the notes in an amount up to the full amount of the underwriting discount indicated on the cover of this term sheet. BofAS and MLPF&amp;S will offer the notes at the public offering price set forth on the cover page hereof. We or one of
        our affiliates will also pay a fee to LFT Securities, LLC for providing certain electronic platform services with respect to this offering, which will have an adverse effect on the economic terms of the notes. An affiliate of each of TD and BofAS
        has an ownership interest in LFT Securities, LLC. TD will reimburse TDS for certain expenses in connection with its role in the offer and sale of the notes, and TD will pay TDS a fee in connection with its role in the offer and sale of the notes.</div>
      <div style="text-align: justify; margin-top: 5pt;">We will deliver the notes against payment therefor in New York, New York on a date that is greater than one business day following the pricing date. Under Rule 15c6-1 of the Securities Exchange Act
        of 1934, as amended, trades in the secondary market generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the notes more than one business day
        prior to the settlement date will be required to specify alternative settlement arrangements to prevent a failed settlement.</div>
      <div style="text-align: justify; margin-top: 5pt;">The notes will not be listed on any securities exchange. In the original offering of the notes, the notes will be sold in minimum investment amounts of 100 units. If you place an order to purchase
        the notes, you are consenting to MLPF&amp;S and/or one of its affiliates acting as a principal in effecting the transaction for your account.</div>
      <div style="text-align: justify; margin-top: 5pt;">MLPF&amp;S, BofAS or our or their affiliates may repurchase and resell the notes, with repurchases and resales being made at prices related to then-prevailing market prices or at negotiated prices,
        and these prices will include MLPF&amp;S&#8217; and BofAS&#8217; (or such other entity&#8217;s) trading commissions and mark-ups or mark-downs. MLPF&amp;S and BofAS (or such other entity) may act as principal or agent in these market-making transactions, but is not
        obligated to engage in any such transactions. At MLPF&amp;S&#8217; and BofAS&#8217; discretion, MLPF&amp;S and BofAS may offer to buy the notes in the secondary market at a price that may exceed TD&#8217;s initial estimated value of the notes for a short,
        undetermined initial period after the issuance of the notes. Notwithstanding the foregoing, any price offered by us, MLPF&amp;S, BofAS or our or their affiliates for the notes will be based on then-prevailing market conditions and other
        considerations, including the performance of the Underlying Fund and the remaining term of the notes. However, none of us, MLPF&amp;S, BofAS or any of our or their respective affiliates is obligated to purchase your notes at any price or at any
        time, and we cannot assure you that we, MLPF&amp;S, BofAS or any of our or their respective affiliates will purchase your notes at a price that equals or exceeds the initial estimated value of the notes.</div>
      <div style="text-align: justify; margin-top: 5pt;">BofAS has informed us that, as of the date hereof, it expects that if you hold your notes in a BofAS account, the value of the notes shown on your account statement will be based on BofAS&#8217; estimate
        of the value of the notes if BofAS or another of its affiliates were to make a market in the notes, which it is not obligated to do. That estimate will be based upon the price that BofAS may pay for the notes in light of then-prevailing market
        conditions, and other considerations, as mentioned above, and will include transaction costs. At certain times, this price may be higher than or lower than our initial estimated value of the notes.</div>
      <div style="text-align: justify; margin-top: 5pt;">TDS is an affiliate of TD and, as such, has a &#8220;conflict of interest&#8221; in this offering within the meaning of Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Rule 5121. Additionally, TD will
        receive the net proceeds from the initial public offering of the notes, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. Consequently, this offering of the notes will be conducted in compliance with the
        provisions of FINRA Rule 5121 and TDS is not permitted to sell the notes to an account over which it exercises discretionary authority without the prior specific written approval of the account holder.</div>
      <div style="text-align: justify; margin-top: 5pt;">The distribution of the Note Prospectus in connection with these offers or sales will be solely for the purpose of providing investors with the description of the terms of the notes that was made
        available to investors in connection with their initial offering. Secondary market investors should not, and will not be authorized to, rely on the Note Prospectus for information regarding TD or for any purpose other than that described in the
        immediately preceding sentence.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">12</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Structuring the Notes</div>
      <div style="text-align: justify; margin-top: 5pt;">The notes are our senior unsecured debt securities, Series H, the return on which is linked to the performance of the Underlying Fund. As is the case for all of our debt securities, including our
        market-linked notes, the economic terms of the notes reflect our actual or perceived creditworthiness at the time of pricing. Our internal funding rate generally represents a discount from the credit spreads for our conventional fixed-rate debt
        securities and the borrowing rate we would pay for our conventional fixed-rate debt securities. If the interest rate implied by the credit spreads for our conventional fixed-rate debt securities, or the borrowing rate we would pay for our
        conventional fixed-rate debt securities were to be used, we would expect the economic terms of the notes to be more favorable to you. Therefore, due to these factors, the public offering price you pay to purchase the notes is greater than the
        initial estimated value of the notes.</div>
      <div style="text-align: justify; margin-top: 5pt;">At maturity, we are required to pay the Redemption Amount to holders of the notes, which will be calculated based on the performance of the Underlying Fund and the $10 per unit principal amount. In
        order to meet these payment obligations, at the time we issue the notes, we may choose to enter into certain hedging arrangements (which may include call options, put options or other derivatives) with BofAS, MLPF&amp;S or one of their affiliates.
        The terms of these hedging arrangements are determined by seeking bids from market participants, which may include MLPF&amp;S, BofAS and one or more of our or their affiliates, and take into account a number of factors, including our
        creditworthiness, interest rate movements, the volatility of the Underlying Fund, the tenor of the notes and the tenor of the hedging arrangements. The economic terms and initial estimated value of the notes depend, in part, on the terms of these
        hedging arrangements.</div>
      <div style="text-align: justify; margin-top: 5pt;">BofAS has advised us that the hedging arrangements will include a hedging related charge of approximately $0.05 per unit, reflecting an estimated profit to be credited to BofAS from these
        transactions. Since hedging entails risk and may be influenced by unpredictable market forces, additional profits and losses from these hedging arrangements may be realized by BofAS or any third party hedge providers.</div>
      <div style="text-align: justify; margin-top: 5pt;">For further information, see &#8220;Risk Factors&#8212;Conflict-Related Risks&#8221; herein and &#8220;Use of Proceeds and Hedging&#8221; on page PS-23 of product supplement EQUITY LIRN-1.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">13</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Summary of Canadian Federal Income Tax Consequences</div>
      <div style="text-align: justify; margin-top: 6pt;">For a discussion of the Canadian federal income tax consequences of investing in the notes, please see the discussion in product supplement EQUITY LIRN-1 under &#8220;Supplemental Discussion of Canadian
        Tax Consequences&#8221; and under &#8220;Tax Consequences &#8211; Canadian Taxation&#8221; in the accompanying prospectus. If you are not a Non-resident Holder (as that term is defined in the prospectus) for Canadian federal income tax purposes or if you acquire the notes
        in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the notes and receiving the payments that might be due under the notes. We will not pay any additional amounts as a result
        of any withholding required by reason of the rules governing hybrid mismatch arrangements contained in section 18.4 of the Canadian Tax Act (as defined in the prospectus).</div>
      <div style="text-align: justify; margin-top: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Supplemental Discussion of U.S. Federal Income Tax Consequences</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The U.S. federal income tax consequences of your investment in the notes are uncertain. No statutory, regulatory, judicial or administrative authority directly discusses how the
        notes should be treated for U.S. federal income tax purposes. Some of these tax consequences are summarized below, but we urge you to read the more detailed discussion under &#8220;Material U.S. Federal Income Tax Consequences&#8221; beginning on page PS-43 of
        product supplement EQUITY LIRN-1 and to discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), final, temporary and proposed
        U.S. Department of the Treasury (the &#8220;Treasury&#8221;) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. Tax consequences under state,
        local and non-U.S. laws are not addressed herein. No ruling from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) has been sought as to the U.S. federal income tax consequences of your investment in the notes, and the following discussion is not
        binding on the IRS. Except as discussed under the heading &#8220;Non-U.S. Holders&#8221;, this discussion is applicable only to a U.S. holder that acquires notes upon initial issuance and holds its notes as a capital asset for U.S. federal income tax purposes.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">U.S. Tax Treatment. </font>Pursuant to the terms of the notes, TD and you agree, in the absence of a statutory or regulatory change or an administrative
        determination or judicial ruling to the contrary, to characterize your notes as prepaid derivative contracts with respect to the Underlying Fund. Holders are urged to consult their tax advisors concerning the significance, and the potential impact,
        of the above characterization. If your notes are so treated, upon the taxable disposition (including cash settlement) of a note, you generally should recognize gain or loss in an amount equal to the difference between the amount realized on such
        taxable disposition and your tax basis in the note. Your tax basis in a note generally should equal your cost for the note. Subject to the discussion below regarding Section 1260 of the Code, such gain or loss should generally be long-term capital
        gain or loss if you have held your notes for more than one year (otherwise such gain or loss should be short-term capital gain or loss if held for one year or less) The deductibility of capital losses is subject to limitations.</div>
      <div style="text-align: justify; margin-top: 5pt;"><font style="font-style: italic;">Section 1260</font>. Because the Underlying Fund would be treated as a &#8220;pass-thru entity&#8221; for purposes of Section 1260 of the Code, it is possible that an investment
        in the notes could be treated as a &#8220;constructive ownership transaction&#8221; within the meaning of Section 1260 of the Code. If the notes were treated as a constructive ownership transaction, certain adverse U.S. federal income tax consequences could
        apply (i.e., all or a portion of any long-term capital gain that you recognize upon the taxable disposition of your notes could be recharacterized as ordinary income and you could be subject to an interest charge on deferred tax liability with
        respect to such recharacterized gain). We urge you to read the discussion concerning the possible treatment of the notes as a constructive ownership transaction under &#8220;Material U.S. Federal Income Tax Consequences &#8212;&#8211; Section 1260&#8221; in product
        supplement EQUITY LIRN-1.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is of the opinion that it would be
        reasonable to treat your notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the notes, it is possible that your notes could alternatively be treated for tax purposes as a
        single contingent payment debt instrument or pursuant to some other characterization (including possible treatment as a &#8220;constructive ownership transaction&#8221; under Section 1260 of the Code), such that the timing and character of your income from the
        notes could differ materially and adversely from the treatment described above, as described further under &#8220;Material U.S. Federal Income Tax Consequences &#8212; Alternative Treatments&#8221; on page PS-46 of product supplement EQUITY LIRN-1.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Notice 2008-2. </font>In 2007, the IRS released a notice that may affect the taxation of holders of the notes. According to Notice 2008-2, the IRS and the Treasury
        are considering whether a holder of an instrument such as the notes should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is possible, however, that
        under such guidance, holders of the notes will ultimately be required to accrue income currently and this could be applied on a retroactive basis. According to the Notice, the IRS and the Treasury are also considering other relevant issues,
        including whether additional gain or loss from such instruments should be treated as ordinary or capital, whether non-U.S. holders of such instruments should be subject to withholding tax on any deemed income accruals, and whether the special
        &#8220;constructive ownership rules&#8221; of Section 1260 of the Code (discussed above)<font style="font-size: 8pt;">&#160;</font>should be applied to such instruments. Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the
        significance, and the potential impact, of the above considerations on their investments in the notes.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">14</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Proposed Legislation</font>. In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of notes purchased after the
        bill was enacted to accrue interest income over the term of the notes despite the fact that there will be no interest payments over the term of the notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">Furthermore, in 2013 the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the effect of this legislation
        generally would have been to require instruments such as the notes to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</div>
      <div style="text-align: justify; margin-top: 6pt;">Except to the extent otherwise required by law, TD intends to treat your notes for U.S. federal income tax purposes in accordance with the treatment described above and under &#8220;Material U.S. Federal
        Income Tax Consequences&#8221; of the product supplement EQUITY LIRN-1, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Medicare Tax on Net Investment Income.</font> U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8% tax on all or a portion
        of their &#8220;net investment income,&#8221; or &#8220;undistributed net investment income&#8221; in the case of an estate or trust, which may include any income or gain realized with respect to the notes, to the extent of their net investment income or undistributed net
        investment income (as the case may be) that, when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse), $125,000 for a
        married individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the regular income tax. U.S. holders should consult
        their tax advisors as to the consequences of the 3.8% Medicare tax.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Specified Foreign Financial Assets</font>. Certain<font style="font-style: italic;">&#160;</font>U.S. holders that own &#8220;specified foreign financial assets&#8221; in excess of
        an applicable threshold may be subject to reporting obligations with respect to such assets with their tax returns, especially if such assets are held outside the custody of a U.S. financial institution. Significant penalties can apply if a U.S.
        holder is required to disclose its notes and fails to do so.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Backup Withholding and Information Reporting</font>. The proceeds received from a taxable disposition of the notes will be subject to information reporting unless
        you are an &#8220;exempt recipient&#8221; and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as an accurate taxpayer number, if you are a U.S. holder) or meet certain
        other conditions.</div>
      <div style="text-align: justify; margin-top: 6pt;">Amounts withheld under the backup withholding rules are not additional taxes and may be refunded or credited against your U.S. federal income tax liability, provided the required information is
        furnished to the IRS.</div>
      <div style="text-align: justify; margin-top: 4pt;"><font style="font-style: italic;">Non-U.S. Holders.</font> If you are a non-U.S. holder, subject to Section 871(m) of the Code and FATCA, discussed below, you should generally not be subject to
        generally applicable information reporting and backup withholding requirements with respect to payments on your notes if you comply with certain certification and identification requirements as to your non-U.S. status, including providing us
        (and/or the applicable withholding agent) a properly executed and fully completed applicable IRS Form W-8. Subject to Section 897 of the Code and Section 871(m) of the Code, discussed herein, gain realized from the taxable disposition of a note
        generally will not be subject to U.S. tax unless (i) such gain is effectively connected with a trade or business conducted by you in the U.S., (ii) you are a non-resident alien individual and are present in the U.S. for 183 days or more during the
        taxable year of such taxable disposition and certain other conditions are satisfied or (iii) you have certain other present or former connections with the U.S.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Section 897. </font>We will not attempt to ascertain whether the Underlying Fund would be treated as a &#8220;United States real property holding corporation&#8221; (&#8220;USRPHC&#8221;)
        within the meaning of Section 897 of the Code. We also have not attempted to determine whether the notes should be treated as &#8220;United States real property interests&#8221; (&#8220;USRPI&#8221;) as defined in Section 897 of the Code. If the Underlying Fund and/or the
        notes were so treated, certain adverse U.S. federal income tax consequences could possibly apply, including subjecting any gain realized by a non-U.S. holder in respect of the notes upon a taxable disposition of the notes to U.S. federal income tax
        on a net basis, and the proceeds from such a taxable disposition to a withholding tax. Non-U.S. holders should consult their tax advisors regarding the potential treatment of the Underlying Fund as a USRPHC and/or the notes as USRPI.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Section 871(m).</font> A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section 871(m) of the Code on certain
        &#8220;dividend equivalents&#8221; paid or deemed paid to a non-U.S. holder with respect to a &#8220;specified equity-linked instrument&#8221; that references one or more dividend-paying U.S. equity securities or indices containing U.S. equity securities. The withholding
        tax can apply even if the instrument does not provide for payments that reference dividends. Treasury regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on specified equity-linked instruments that
        have a delta of one (&#8220;delta-one specified equity-linked instruments&#8221;) issued after 2016 and to all dividend equivalents paid or deemed paid on all other specified equity-linked instruments issued after 2017. However, the IRS has issued guidance
        that states that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not apply to specified equity-linked instruments that are not
        delta-one specified equity-linked instruments and are issued before January 1, 2027.</div>
      <div style="text-align: justify; margin-top: 6pt;">Based on our determination that the notes are not &#8220;delta-one&#8221; with respect to the Underlying Fund<font style="font-size: 8pt;">,</font> our special U.S. tax counsel is of the opinion that the notes
        should not be delta-one specified equity-linked instruments and thus should not be subject to withholding on dividend equivalents. Our determination is not binding on the IRS, and the IRS may disagree with this determination. Furthermore, the
        application of Section 871(m) of the Code will depend on our determinations made when the terms of the notes are set. If withholding is required, we will not make payments of any additional amounts.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">15</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt;">Nevertheless, after the date the terms are set, it is possible that your notes could be deemed to be reissued for tax purposes upon the occurrence of certain events affecting the Underlying Fund<font style="font-size: 8pt;">&#160;</font>or your notes, and following such occurrence your notes could be treated as delta-one specified equity-linked instruments that are subject to withholding on dividend equivalents. It is also possible that
        withholding tax or other tax under Section 871(m) of the Code could apply to the notes under these rules if a non-U.S. holder enters, or has entered, into certain other transactions in respect of the Underlying Fund, any stock included in the
        Underlying Fund or the notes. A non-U.S. holder that enters, or has entered, into other transactions in respect of the Underlying Fund<font style="font-size: 8pt;">&#160;</font>or the notes should consult its tax advisor regarding the application of
        Section 871(m) of the Code to its notes in the context of its other transactions.</div>
      <div style="text-align: justify; margin-top: 6pt; font-style: italic; font-weight: bold;">Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the notes, you are urged to consult your tax advisor
        regarding the potential application of Section 871(m) of the Code and the 30% withholding tax to an investment in the notes.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">U.S. Federal Estate Tax Treatment of Non-U.S. Holders.</font> A note may be subject to U.S. federal estate tax if an individual non-U.S. holder holds the note at the
        time of his or her death. The gross estate of a non-U.S. holder domiciled outside the U.S. includes only property situated in the U.S. Individual non-U.S. holders should consult their tax advisors regarding the U.S. federal estate tax consequences
        of holding the notes at death.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">FATCA.</font> The Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;) was enacted on March 18, 2010, and imposes a 30% U.S. withholding tax on &#8220;withholdable payments&#8221;
        (i.e., certain U.S.-source payments, including interest (and original issue discount), dividends or other fixed or determinable annual or periodical gain, profits and income, and the gross proceeds from a disposition of property of a type which can
        produce U.S.-source interest or dividends) and &#8220;passthru payments&#8221; (i.e., certain payments attributable to withholdable payments) made to certain foreign financial institutions (and certain of their affiliates) unless the payee foreign financial
        institution agrees (or is required), among other things, to disclose the identity of any U.S. individual with an account at the institution (or the relevant affiliate) and to annually report certain information about such account. FATCA also
        requires withholding agents making withholdable payments to certain foreign entities that do not disclose the name, address, and taxpayer identification number of any substantial U.S. owners (or do not certify that they do not have any substantial
        U.S. owners) to withhold tax at a rate of 30%. Under certain circumstances, a holder may be eligible for refunds or credits of such taxes.</div>
      <div style="text-align: justify; margin-top: 6pt;">Pursuant to final and temporary Treasury regulations and other IRS guidance, the withholding and reporting requirements under FATCA will generally apply to certain &#8220;withholdable payments&#8221;, will not
        apply to gross proceeds on a sale or disposition and will apply to certain foreign passthru payments only to the extent that such payments are made after the date that is two years after final regulations defining the term &#8220;foreign passthru
        payment&#8221; are published. If withholding is required, we (or the applicable paying agent) will not be required to pay additional amounts with respect to the amounts so withheld. Foreign financial institutions and non-financial foreign entities
        located in jurisdictions that have an intergovernmental agreement with the U.S. governing FATCA may be subject to different rules.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">Investors should consult their own advisors about the application of FATCA, in particular if they may be classified as financial institutions (or if they hold their notes through
        a foreign entity) under the FATCA rules.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Both U.S. and non-U.S. holders should consult their tax advisors regarding the U.S. federal income tax consequences of an investment in the notes, as well as any tax consequences
        arising under the laws of any state, local or non-U.S. taxing jurisdiction (including that of TD).</div>
      <div style="font-weight: 400;"> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">16</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 1%;">&#160;</td>
                <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 99%;">
                  <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                  <div style="color: rgb(91, 134, 43);">Linked to the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF due December 28, 2026</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Validity of the Notes</div>
      <div style="text-align: justify; margin-top: 5pt; margin-bottom: 1.5pt;">In the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP, as special products counsel to TD, when the notes offered by this term sheet have been executed and issued by
        TD and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the notes will be valid and binding obligations of TD, enforceable against TD in accordance with their terms, subject to
        applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors&#8217; rights generally, and to general principles of equity (regardless of whether enforcement is sought
        in a proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Canadian law, Fried, Frank, Harris, Shriver &amp; Jacobson
        LLP has assumed, without independent inquiry or investigation, the validity of the matters opined on by McCarthy T&#233;trault LLP, Canadian legal counsel for TD, in its opinion expressed below. In addition, this opinion is subject to customary
        assumptions about the trustee&#8217;s authorization, execution and delivery of the indenture and, with respect to the notes, authentication of the notes and the genuineness of signatures and certain factual matters, all as stated in the opinion of Fried,
        Frank, Harris, Shriver &amp; Jacobson LLP filed as Exhibit 5.3 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
      <div style="text-align: justify; margin-top: 5pt;">In the opinion of McCarthy T&#233;trault LLP, the issue and sale of the notes has been duly authorized by all necessary corporate action on the part of TD, and when this term sheet has been attached to,
        and duly notated on, the master note that represents the notes, the notes will have been validly executed and issued and, to the extent validity of the notes is a matter governed by the laws of the Province of Ontario, or the laws of Canada
        applicable therein, will be valid obligations of TD, subject to the following limitations: (i) the enforceability of the indenture is subject to bankruptcy, insolvency, reorganization, arrangement, winding up, moratorium and other similar laws of
        general application limiting the enforcement of creditors&#8217; rights generally; (ii) the enforceability of the indenture is subject to general equitable principles, including the fact that the availability of equitable remedies, such as injunctive
        relief and specific performance, is in the discretion of a court; (iii) courts in Canada are precluded from giving a judgment in any currency other than the lawful money of Canada; and (iv) the enforceability of the indenture will be subject to the
        limitations contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find any provision of the indenture to be unenforceable as an attempt to vary or exclude a limitation period under that
        Act. This opinion is given as of the date hereof and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable thereto. In addition, this opinion is subject to: (i) the assumption that the senior indenture has been
        duly authorized, executed and delivered by, and constitutes a valid and legally binding obligation of, the trustee, enforceable against the trustee in accordance with its terms; and (ii) customary assumptions about the genuineness of signatures and
        certain factual matters all as stated in the letter of such counsel dated December 20, 2024, which has been filed as Exhibit 5.2 to the Registration Statement on Form F-3 filed by TD on December 20, 2024.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Where You Can Find More Information</div>
      <div style="text-align: justify; margin-top: 6pt;">We have filed a registration statement (including a product supplement and a prospectus) with the SEC for the offering to which this term sheet relates. You should read the Note Prospectus, including
        this term sheet, and the other documents that we have filed with the SEC, for more complete information about us and this offering. You may get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, we, any
        agent, or any dealer participating in this offering will arrange to send you these documents if you so request by calling MLPF&amp;S or BofAS toll-free at 1-800-294-1322.</div>
      <div style="text-align: justify; margin-top: 6pt;">&#8220;Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>&#8221; and &#8220;LIRNs<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>&#8221; are registered service marks of Bank of America Corporation, the parent company of MLPF&amp;S and BofAS.</div>
      <div><br>
      </div>
      <div><br>
      </div>
    </div>
  </div>
  <div class="BRPFPageFooter" style="width: 100%;">
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50.00%;">
                <div style="text-align: left; color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
              </td>
              <td style="width: 50.00%;">
                <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">17</font></div>
              </td>
            </tr>

        </table>
        <div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Oct 31 16:56:26 UTC 2025 -->
<!--?xml version="1.0" encoding="ASCII"?-->
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 04 23:02:01 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title> </title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc. Document created using Broadridge PROfile 25.1.1.5279 Copyright 1995 - 2025 Broadridge -->



<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font-family: Arial; font-size: 9pt; text-align: left; color: rgb(0, 0, 0);"><div>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-bottom: 20px;">

      <div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;">Calculation of Filing Fee Tables</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-32">F-3</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-33">TORONTO DOMINION BANK</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 12pt; font-weight: bold;">Narrative Disclosure</div>
        <div style="text-align: center; font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>

        <ix:nonNumeric contextRef="c0" escape="true" name="ffd:NrrtvDsclsr" id="ixv-26"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:NrrtvMaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-34">5,951,030.00</ix:nonFraction></span>. The prospectus is a <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ffd:FnlPrspctsFlg" id="ixv-35">final prospectus</ix:nonNumeric> for the related offering.</div></ix:nonNumeric><div><br/>
        </div>
      </div>
    </div>
  </div></div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="ffd:CombinedProspectusTableNa" id="ixv-38">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-39">0000947263</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-40">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OfferingTableNa" id="ixv-41">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OffsetTableNa" id="ixv-42">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:RegnFileNb" id="ixv-43">333-283969</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:SubmissnTp" id="ixv-44">424B2</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000947263</xbrli:identifier>
  </xbrli:entity>
<!-- [WMV6][ztUlOLJ99J6C9yMk6T8I8ART+Z73Fk7iUN3zNs9GzkY26sUBLoQlfznBpfnZ6d547Z1wHQBHhWXPcFNMPd4Cgf25RNJzcdQLLraPvk4VZbwlfrw3qD1LqNW6fUfJmDuHe/yWDbRPBPM3VziSUB7cqdziqXcisOFjYwTT59DThFQ3kEQAExr+412zVnqcCI7vi5us9QuC7mn6o2B+lZeeSGQUT+YZqQl6HLAkJ5qD7SYmQ4jHidleDKCtIwEnPloBp0b4nZmmgODtp5cjLgMizq7/GVN1qeuaz76WZ+gGS9vwI3fpCV+RCxBXyQpnoaIXwx9eqTirnXhee2kIpJLEQYsct/JV6Ydu6C4GtDNQDWIEcg6h2ZRjtPyFPBqqlh/DffUApAZT2BdVPCDWYK+6wLUMRDHNBRK1Mh8MXwcVE//LrRJKJp03wIc2li8T] CSR-->
  <xbrli:period>
    <xbrli:startDate>2025-10-30</xbrli:startDate>
    <xbrli:endDate>2025-10-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>
</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) %$# 2(  A$! Q$!_\0
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MVO/^C5OVD/\ PQWQ._\ F7KL_L+//^A-FO\ X;L7_P#*3U_]2.-/^B0XH_\
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M_%.'_J\O_G//_P >3_-_HK_2 HH_XEG_ .JV_P#-;_\ P\'_ !3A_P"KR_\
(G//_ ,>3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  S -,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BODK]H_P#;A_9R_90\8?"'X>?&3Q!\14^(/Q[/CO\ X5!X"^%7
M[/W[0O[0_C?QR/AEIVC:QX\?2_"7[/7PL^*7B"&+PSI.OZ7J6H3:CIUE$;&:
MXNK=YX-/U%[7ZETG4[;6M*TS6;.+4(;35M/LM3M8=6TG5= U6*VO[:.Z@CU/
M0M=LM.UO1=02*55O=)UG3[#5=.N1)9ZA96MW#- A#]Y3=:'OTE4E2=6'O4U5
MC.I3E3<U>*J1J4:T)0OS*=*I%J\))$KPE3C-<DJM-UJ49>[*I1C-TY5::=G.
MFJB=-SC>*FG!OF5C0HHHH **** "BBB@ HHKP[6/V@? T/A[XFZUX+L?&'Q?
MU+X4^+!\//$/A+X3^%]0\4^(+SXCM;:/./ NCW4_]E^$Y-5LY=?TJR\3:QJ?
MB?2O!OP_NYKT?$?Q/X0M]$U^XTM-_%:,YRC#GY*<)U:KBZM'#QY*5.,ZE1SQ
M&(P^'A&$)2J5\10HP4JM:G"3MHFW&$7+D]I4E&G3C+V=2K:=6HXTX)4J-:M)
MSE&,:5&K5DU"G.4?<:*^)/V-_P!M31?VJOV4YOVK?$O@+4?@'X;T_P 3_'S1
M/$/A3QIXGT'Q)K'@W3O@!\4?'OPR\4:EXKUGPM]H\+PW:W'P^U?5[^V\.ZOX
MET73X&$5AXGUZ!%U";Y2^%G_  50\7>+==_8\\9?$G]EP_"S]E3_ (*"^+$\
M%_LH?&Y?C1:>+/'TNN>)/!WB;XA?""']H+X,GX;>&M&^$*_'#P?X3O\ 4/A]
M'X*^,7QLO8=1U+P_X?\ &%GX7UB_OK;2M(4Y3Q"PL+3K.6 IVA.$J:JYJZ\<
MJP[K*3HQQ6:U,-B*&5X5U%B,QQ-"MAL%2KXBG.DE)\E/$59WIPPLLW5?G3A*
M"R'F_MJ:A*TYTLK4>?'5J<9TL-3J4:E2<:=>A*I^Q%%?D#\>_P#@J)XU^'=S
M^UYXR^"W[+?_  OW]G[_ ()^ZB-$_:X^(\/QIM/ OC^S\0:/X&T;XI?$K0/V
M>OA3_P *U\8Z5\8M4^$'PY\1:)K7CY?'?Q/^!-I_;%[+X9\*7GBB_P!,U66Q
M_5KP=XN\/>/_  AX5\=^$=3M]:\*>-?#>A^+?#&L6C![75O#WB33+76=%U.V
M<9#V]_IM[;74+ D-'*I'6IIIUJ"Q-/WJ,H8*LI;2^KYEAY8O+,4Z;M56$S3"
MTZN(RS%N"PV8T:&(J8*K7CAZSINJO8U(TJEHU)U,=2C&Z;=;+*F&HYE0;3:6
M(R^MC,-1QM"35;"UJT*5>%.HW%=)1112$%%?"GA[]L3Q+\9?CIXK^%'[+OP?
ML/BUX#^"OQ)/PQ_:3_:!\8_$Q/AE\+_ OC+3/L,WC3X:_">+2O!'Q,\5?&[X
MQ?#ZRO[=_&/AO^POA[\,]"U:YM_"6I_&:R\86WB#0M XSXY?MO?%/1?CS\1/
MV;?V3?V<="_:8^*/P+^#WA;XX?'JW\6_'$? S0/"'ASXA7_B>S^&G@#P7J5C
M\*OC'J/CCXV>/K;P1XMUW1O"&LZ)X \#V.@:;8WGB#XHZ/=Z]I&GW.,J]&.'
MHXN4U'#XBG7KTJK3498:A@ZF82QDDU>G@JF!I3Q>%QM10PF-P[IU<'6KPJTG
M/=X:LJU3#N,55HSP].LO:TN6A7Q.84\JIX:O4Y_9T<7#,JM/!8G"591Q.#Q$
MU3Q=*@S]'J*^0_V9OVW?@1^U-\+/V:?B?X'UR\T,?M5?"K4/BM\+_"/BRS:P
M\0SV?AF/1T\?^$;V[LVOO#+>//AYJ6L?V9XH\*V&OWNJH=)U_5-.M]0T/0=7
MU.RZ[]IC]J[X.?LB>!W^)7QQ?XJ:=X$M++7]5UOQ/\./V>?VA/CWIGA#0_"V
MDR:YXA\2>/G^ ?PN^)LGP]\+:3I,,]]=>*?'$?A_P\L-M=;=39[6X6/IQD'E
M\JL<:X8;V%6K0JSJU*:I1JT,34P=6*K<SHSY,72J89RA.476A*FFY)HY\,WC
M%2^JQG7=:$*E.%.G-U91JTHUX/V7+[2+E1G&KRR@I*$E)I)GT=17$_#7XB^#
M?B_\._ ?Q8^'6L?\)%X ^)G@_P -^/O!&O\ ]GZKI/\ ;?A+Q?H]GK_AW5O[
M*URQTS6M-_M#2;^TN_L&KZ=8:G:>;Y%]9VUS'+"A3JTJM"K4H5Z=2C6HU)TJ
MU&K"5.K2JTY.%2G4IS2G"I":<9PDE*,DXR2::)I5:=:G3K4:D*U&M"%6E5I2
MC4IU:=2*G"I3G!N,X3BU*$XMQE%IIM-,[:BOY9_'/Q[_ &E_VDO^"G/C_P#9
MY@_;.U+]A_\ :8^$.I_M0>%/V4?@QJ'P;^#TWA'QG\)W\+?!K6/A/\7-8N?C
M;\-?&?BG]H'PW\=M8T/QX_C9/@GXU\'WW@?0_ +:#HT?A7Q!8:MX@\1_IK_P
M4<^.G[8OP"TS]EWQ#\+?%_P@\$^!/&'[6O[&'P/^*]Y+X/U7QU\1_&UI\<_C
MKX4^'?CS2?!IUVZTKP5\+-'TS1M2FFM?$6IZ-\5]?\2+JTMG8Z?\.;S0K?7M
M:SPB>,CDLH+D>?XW(<%@(5='S\1UL)A\NG7E'GI4E'$8VA0QU!5)XS 5W+#X
MO#4L1"5%57:H5,RIRO-Y30SFOC7!:0614ZU?%QA"7+5FJ^'H5<1@*_LUA,=A
MXK$8?$3H5:-2I^L=%?FO^W;\?_BOX7^+G[$O[(GP0\83?"OQY^VC\5_B'H6O
M?&FQ\.>%/%GB'X4_"+X)_"S7/BI\1=8\ :%X]TSQ#X"N?B5XCFL_#'@OPE>^
M-_"'CKPKH">(-6\1:IX*\2'2;?3Y,#]@+X^_&S7/CQ^WE^QE^T#X_N/C)XU_
M8T^)OPE_X0KXVZEX+\+^!O$GQ+^"_P ?OA-I7Q'\#S>/-)\ Z#X2^'ES\0/"
M>N6_C3PIX@UGP%X,\&^%]6L].T6XMO#EGJ*ZJTCH?[0\0HM0="CB:\54?^\T
ML)7RG"UY8=PYU)PKYO3I\M5TIR>#S!QBUA6YNK^Y5.[4G4CAIM0N_8T\74S.
MC2G6;2C!>VRR5*2YG-3QN7+E:Q<7']1Z***0'X??MU?\IF?^"&O_ &#O^"E'
M_J@/AU7[@U^'W[=7_*9G_@AK_P!@[_@I1_ZH#X=5\T?MZ?M(?%/Q3_P4M^&'
M[(7CG]J3Q3^PMX5T[XB? SQ-^R3XB\/?#;X0.?V@-<\6?"WXQZ5\4?'5M\3_
M -HKX9_%3X;>)-;^%GCK6/ OPQL/@OX;T_P_XBEA\:76NZDGB"75M O/"JI5
M)?4>&,)"E4K5LQS+.,#2A2Y74_?\99[&I.G3E*#Q%2C1]I76'I7J3A2J5:CH
M8.CB\9AKKJ,?KV+G4C3IY=PR\QJ.:GR26$GFM2%.<XQDJ4*M10IRJR4G",G[
M&EBL4Z&$Q']+%%?CC_P4/^+?_!0']DW_ ()B>-OBYX-^*7P%E^/7P(_9XO?%
MWQC^-&J_#?6M>A\7^./"NFZ39WLOPQ^$*ZEX>\)^&)?&E[-J6NGQ%XK\0>)]
M#\"RVT&CP_"KQO::K]LT#W/_ (*$?M.?$O\ 9R_9Y^$,?PEN]+3XW?M*?M ?
MLZ?LI?#CQEXHT.VU_1/!'BCX[^++#0-:^*.L^&H;O0=/UV7P/X1@\5>+-)\/
M-<6.DZQXFT_1M*O+:32;FYLI-)P:J0I4Y1KSQ&;X#)<#&F^7Z_C,TS"&59>Z
M/M_8^PHXO,)PP].>/^I2C&<,54A3P4X8F67-RTJ-:K&5"G/+\XS+$.JDU@<-
MD."P68YK]9=)U8U9X7!8ZE7:P#QL*CIUZ%.<\53]@_T;HK\E_P!FWXR?'_X5
M?\%$?BW_ ,$_OCE\;?$_[2_AB\_93\!?M<? SXP^/_ /PN\%_$W3K&;XG>)_
MA)\5?AKX[NO@A\/?A+\*O$=OIFL6O@WQ)X*O]#^&V@:U9:9K.KV'B6^UF4:5
M<K^L[%@K%5W, 2JD[0S < M@[<GC.#CK@U,N58;#XR,E5P^)I8FK2G2A5E*3
MP6.QF5XZE[)TU6=7"YEEV.P4U&G*-:KAI5,+/$8:I0KU:E[F(Q.%DG&MA7@U
M6B[67U_+,!F^%:DFXM5,!F6$K/6\'4=.:C.$XI:*_,FQ_P""I'P7T?X+_$'Q
MA\6?"?C3X9?M#?"3Q=H_PD\?_L7>59^+OVA[SX[>+0Z?#3X:?"?P_HSPQ_%[
M2_C6RC5O@S\3_#2P?#_Q7X-&I^,M<UCPCI/@_P"(?_"&_H3X"U?Q9K_@?P=K
MOCOPA%\/O&VL^&-"U7Q=X#@\1V?C"+P7XDU#3+:[UKPHOBO3K/3].\2?\(_J
M,MQI3:YI]G;V&J-:&]LHQ;31$D5STY586G1C*A%5HM2HU)8G"T\=2C1JING7
MD\%7PN+J*C*HZ.&QV75ZWLZ68X&>(3DE+V;:52]92HMVK4_J]:6'J2K47:K1
M@\1"M1HU*L(0Q%7#8N&'E5E@\4J7R/\ \%&OVAO%/[-?[)GC[Q?\-_+;XT>/
M-9\!? +X PS6Z75NWQW_ &A/'&@?![X57][;RS6\4NE>'?%?C"P\5:XCS+NT
M/0M2$:7$QBMIO4?AUX7^"_[#7[,7A'PGX@\>^'O 'PB^!_@G3=/\2?%'XK^,
M-)\/:=+<><C^(_B#\1?'7BB^T_3/^$B\<^+M2U#Q-XK\1ZS?PR:UXK\0W]]<
MRM=WYW? /_!4@'Q1^TA_P1N^%-S\VC>)_P#@HY9?$75K9RT=O=R_ O\ 9R^.
MGQ$T"*:1"[.;?Q+;:1J$%G);2VUU-9(9IK1X():_9*IP_.\!F-5-4\35X@JX
M%.<74I2P&69%D6-R^I[/FC*-18[B+/H5I4JE/ZQ36%C64OJE&2JOR1QV7491
ME.C3R2GF4N22I57B,TSO.,OQE%S4)1G3AA>&LKJ865:G6EAJV(Q[I6AB:L)?
MS=?\$MOB#\(OVKO^"2_[3G[-?P,^-'PD^(?Q?U_6/^"FNB2^"O"7Q%\'>(?$
M>B6_QC_:1_:0F^'/B'6]$TW6Y;[3?#'BW3/&?AG6?#_B*]2VT/6-)UG3]0L-
M1FM;J*8^"?#CXK^!?VQ_V=_^"$O[(_PQ?^U_VBOV:OV@OV6_B%^UI\&UM(+K
MXH?LB:5^Q=\(/&N@?$RX^/7AN:6WUOX*SZM\2=.T3X?^"I_'>DZ/<_$*+Q2H
M\(6>J1732P_U@45>':PV+ABX)MK%\$YE4A)KWLPX#Q^:9EE$Z<DE[/"8C%9I
M4688:4:M:K1I4Z>'QF%FY57&)4L52QL*C2GBWQW1C*,6HTL%XA4Z5'.J+@Y.
M53$X>EAL,LMQ2J4Z=&<:T\1A,4JL84?Y2?%/QF\'_LQ?"K_@O9^QM\5!#I_[
M3'[1'QO_ &EOB-^R=\$-4M(KSQI^UYH'[8GP'\+>&_A3%\ / S7,.L?&9;;Q
M[%K'@CXB6/@5-;;P-<:-J%QXQ?084N%M?Z(?V8OA!KOPB_9 _9_^ U]K6IZ!
MXG^&W[.7PO\ A3?>(M)70;O6-#\0>%/AMHGA2\UG2EU;3/$'ABYU'3-3L9;V
MP35-'US0Y;B"%;[3M4L&EMY_I6BLL/#V& >!<I24LHX1R2I5C*=&3P7!649A
MDV3SI^SDJE+%U,-FF+J8^O"KRU:_U>>%I8)4I1JW7?ML9#%I1BJ>8\3YM"G*
M*JKZ]Q?F&69IG'.YITYX6.,RJC]0P\J7-A\/4JT<37QLFJJ^ /\ AC;]HK_I
M+%^W_P#^&Y_X)9?_ $M.OKCX5^"/$_P\\#:;X3\6?&'XB_';Q!82:C)<_$WX
MKZ9\)-(\;:TM[?7%W:P:I8? _P"%OP;^&\4.D031:7I[:-\/M)N);"T@DU6;
M4]3:ZU&Y]'HJVVZ=2GLJD>64DDJD?.G4MSTI:_%3E%OK=:$V3<9.]X2YDN:2
M3=G&THII35F_=FG&]I)<T8M?Q2?!R]TCX#?L+Z_\//"G[3'[0W@C_@M'\-?V
MI_C%?^%?V0]+_:%^)N@^,/B%\6O'/[7.O>*;"+Q)^QQX?U_3OAW\</V?OB]X
M.\2VOBWQ%^T%XW^%/Q TC3_AYXAU3Q4OQ7TC3O"=O;>'OU;_ .&@?A?^P7_P
M5-_X*&^,OVM/%6C?!OP5^U5^SM^R;\4?@+XS\7WUIH_ACXL:]\#/"?Q!^&OQ
M-^#/PZU'4)[>W\:_&O3-6OO#.H:+\*-!GO?B!XGTGQ1IEWHWANXM7AN;K^@"
MBN:I0E/ 4,$JD:/)@\3@:[HTE'#RI8C**.7MX3#S=26%G'&8?#9BY5*^*]I]
M5H8:HI*>-KXRY<M3%9AB*L7-8W&U,9'WY*O&57B*GGLJ6)KMR6*IPI1KY=0Y
M*6%E1IXW%5TW*.#IX3^>[]F/]C'XR>'_ /@A-\"OAO'X>U'X5_M=?"/P%JG[
M67P6T;5[*3PSJWPL_:/M?'/C/X__  ]\%:YI4-PEWHFCW<GB3_A4'Q.\)75T
M)KSP#XF\:^"M<'DZCJ%M7U/^TG^T+X6_:Q_X(??M(_M+>"XOLWAOXW_\$U?C
MK\1K'3FF^T3:)/XE_9V\77VI^'+R;RXM^H>&]6DOM!U$-%$Z7^G7"/%&ZLB_
MK41D$$9!X((R"#U!%?S'_LYZA=I_P;T?\%$_ ES,UQ'\&_#G_!8SX/Z=(4B2
M,:/X)^)/[3%OI$%N84@C>UL]/N[>SMV6QTX"*W5/L4>S?)S<2UUB<JXZC"FH
M1QF39EQ%1PT9/DP*P]+^Q\UK723Q5;'PS/A7!SK5O?I4,BP\8:5:B7K\-QG#
M/N"*]:HJE:GQ/E^3XBNH\M3&ULQKRSO#.4).?L<-@:V4<08BE1IU6OK.?XF3
MC.\JD?V8_P"":W_*.W]A'_LSW]FW_P!4]X/HH_X)K?\ *.W]A'_LSW]FW_U3
MW@^BOK^*/^2FXB_['N;_ /JPQ!\7PU_R3G#_ /V),J_]0*!^&W_!5'X:?M8?
MME_%WP/^R[XP_8;L?$?Q4;PE^W%'^R/\?M&^+OPD\-_"3P//-\1/V?9_@1^U
M);^)=1^)G_#17PO^)WP \-0:%J_Q*LO"/PJO=:USQ;?OX?\ AH?$O@OQ/XI_
MX17]"O\ @I]X&_:D\9_"+]ECX5?!C]F+XQ?M3>*/AA^TK^QK^T!X\\?^#O''
M[,'@3PY<Z9^SE\9/"'CKQWI=W_PO3]HGX6^*)/''BO2O#-]>>';?2_#6L>&9
MK_4K.UUCQ9I/^ES6W[+T5X.&7U18"5%\M? YQD^>RQ'+'FQ>89#F#S++:E>D
MXO#TU]9Y:F->$I8:ICW&G1Q%26"P>6X/ >_6FJZK0G"+IU<#Q!EL:=YVHX/B
M2DJ&-H4I\WMI4\/13AET,14KQP7M*\X*57$XFI6_)7]LSX3_ +0_Q,\<_P#!
M/3]M[X,? WQ1JGQ)_9)^+/CW7_B'^RQXK\6_!S0OBKXF^#GQR^&>N_"GXCZ-
MX3\51_%/4?@(_P 5/"3S>&O&?AS3=4^,6D^#M>M-/U#3+GX@:1=NME>]_P#L
M*? 7XN>'?C3^W#^U_P#'+P0/A3XU_;,^*'PQU#PI\'M1\0^'/%OC/X7_  ;^
M!?PHT7X7^ -%^(NO>!_$OC+X=#QYXAU.+Q?XWU_0_AQXP\8>#M"_X2.SLK/Q
M;KM\+^6#]*Z*=*U&IBIPBK8F.+A&F[RIX6EC*V48BM2PO,W.,/;9/0JP]K.M
M.,\5F$N=RQE5F-2+JK"\TGS8:CAZ,YQ4(RQ<<-4S.K3EBDH\CFZF:5)SE1A0
MYGA,OBUR82$7\G?%W]@K]AC]H'QG<_$?X\_L7_LG?&WXAWEC8:7>>//B[^SI
M\'_B3XSNM,TJ$V^EZ=<^*/&7@[6M<GL=-MR8+"TEOFM[.$F*WCC3Y:N?!G]A
MK]B?]G+Q9/X]_9Z_8]_9:^ _CJZT>[\.W/C3X,_L^_";X7^++CP_J%Q9W=_H
M4_B/P1X1T/6)='O;K3M/N;O3)+QK*YN+&SFF@>2V@9/J6BBE^YO[']U?VM_9
M?N[^WY_;WY;7]M[2I[6_\3VD^?FYI7J?[VWM/WEO9VY_?M['E]E;FO;V7)#V
M?\G)'EMRJWX??MU?\IF?^"&O_8._X*4?^J ^'5>4_P#!7"/XW?%CQ%\.OV;_
M (K_ /!/^V_:P_9_\<?M0Z"GP5;PS\0?@?I/ACXAPW_[(/QFL[[P!\9K+XQ?
M%3P9XH\!>.] ^*L_B/QGX;^(/@/PIXDT31O /AS2]>T>^MOBQHNB>'_%'JW[
M=7_*9G_@AK_V#O\ @I1_ZH#X=5^X-8RPM+%Y-DM/$)U*'UG.)UJ#2Y:M/#\=
MYIC6HR<7*C7OA5&CB(:T7.3E"M2E4H5.E8B>&Q52=+2K5X?EA:53FG'V,\;#
M.L'[5J$H.I"*KOVE+FA.I3<XT*^%Q/L<70_!#]J7]F[]LO3/^"'^G?L%Z9\+
M/B'^V#^U1XR_9%TOX"^*_%W@?XC?!NP\.Z-\0+#POHUG<:YXT\<?M(?&+X.Z
M[KWAC[9%/I-GXCT/3/%?BS58M-_M75_#.FR7B1'W7]M+X/?M'?MA_L>_!SQ9
M\.?@9XB^$'[3'[-7[2/[/7[47@+X#?'?QC\'UNO'&N? 'Q;INL:[X"O?''P;
M^)OQ?^&VCQ>/_"5[XKT'PIKEWXK:&U\0-I<OB*'POI\LFLV'Z]45VXG$5<5C
M*^/J2MBJF<Y?GV'J027U',LKS.&;X*KAHRYHSA2QM*G-TL:L9&I"/)4YHN5^
M*G2IT\-@<&H1EA,'EN;93/#M<M/&X#/,'A<OS*CBO9^SE!5\%A*6&B\#+!.C
M!SG1=.JU4C^67[.7P>^-_P 3?V]_BS^WY\:O@UKW[.FBR?LO_#O]DWX*_!OX
MB>*_AGXP^+<>EZ3\1?%7Q9^*?Q%\;2_!/XD_%SX1>'+'Q+XBUCPKX=\(:5X;
M^(GB77=1T;PC-JWBJ'PW<3V.C']29G>.*62.%[AXXW=((S&LDSJI98HVFDBA
M5Y" BM++'&&(,DB+EA)16&V&H82G^YHX:&*C04/>=*6.Q^-S7%U$ZOM.:=?,
MLQQN,DI\U.%3$2I4J=/#0I4*=I/V]?$U).M7Q,L)*O.:C'VBP.7X+*L+%QHQ
MI1C&CE^78/#)P49SC1]I4E.M.I5E^%/C#_@G3^TQ\;OB'IG_  4A\8>-_!GP
MS_X*7?#%)#^RG\/K0V_BS]G7X*?!N >((]0_96^*6I6^DVVL_%.\^.&A^)?$
M%C\:?CUIT=OKGP[\7:]8:E\!M,L_#/@5].^(_P"U?@35?%.N^"/!VM^.?":>
M _&NK^%] U/Q?X(BUVR\4Q>#_$]]I5K<Z_X7A\3:;%!I_B*'0=5EN]+AUVRM
M[>UU:.U6_@MX([A84ZNBG3M2H?5:<5'#0G&IAJ&LHX.4O:2Q?U>I)RKM9C6F
ML;CUB*M=5\R6(S5>SS+-<[Q>9JI'VF(>+FY/$3A*G7JWUQ,(JC'"0K1_AJ.7
M4:3PN 5&%+V.#J1P<O:87"9?2P?XV_\ !4@GPO\ M(?\$;OBM<C;HWAC_@HY
M9?#O5KEPTEO:2_'3]G+XZ?#O0)9HT",AN/$MSI&GP7DES';6LUZ@FANWG@BK
M]$_CI^R=^RS^U!_PBW_#2_[-/P _:(_X0?\ MO\ X0K_ (7I\&_AU\6_^$/_
M .$F_LC_ (2/_A%O^$_\.>(/^$?_ .$@_P"$?T'^V_[)^R?VK_8FD?;_ #_[
M-L_)\9_X*-?L\^*?VE/V3/'WA#X;^6GQH\!ZSX"^/OP!FFN$M;=?CO\ L]^.
M- ^,/PJL+VXEAN(HM*\1>*_!]AX5UQWA;;H>NZD8WMYA%<P_07[/?QL\+?M&
M_!/X9_&_P9'?VFA?$?PKI^OKH^L6LFGZ_P"&-78/9^)?!?BC3)L7&D>+?!'B
M6TU?PCXMT6Y"W6C>)-%U32[I5N+210873!9A2E>5:GQ!5QS=K0AE^9Y#D6"P
M$(R;7M*KQ_#N?3K0IJ:P].6%G6E%XNC%O%:XS 5EI">10RY1^*7UK*L[SC,,
M75GRW5*C/#<2Y73PWM>26(JX?'^RC..&J27S'_PZ=_X)9?\ 2-/]@#_Q#?\
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-$4HPA%*,8I))))'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image2.jpg
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  S 3\# 2(  A$! Q$!_\0
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M(5J-&I5A"&(JX;%PP\JLL'BE2ZVBOEK]I#P-^U-\1-3^%/AC]G_XU>&_@#X
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M8KX_:4_9?A]^W5_RF9_X(:_]@[_@I1_ZH#X=5Y3_ ,%<(_C=\6/$7PZ_9O\
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MM(X3$9_A:R^*4ZN=8?(<3@7"$;RC2HTN&<T6)KU(QI4ZM? 4>=U<33A+M/\
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A3Q%*:4Z5><Y3E.=:G*\:LIRJU)2E-2<I5)MMN<K_ /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image3.jpg
<TEXT>
begin 644 image3.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  S 3\# 2(  A$! Q$!_\0
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M^SWJKZRHK\Y_@A^W;XAU?XT_'O\ 9K_:Q^$7A7]FOXU_ 3X->%?VD=0?P?\
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M? _AG7)_".O6^EZ1H^N:+JLK80K<\LPIJG45; X"MF4*%H.IF&%H8S)<OJ/
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MG?$W1+7X->!/"/A;Q5'HGBKXE7/@?XF:U>^,K6T_X5IHMK;ZC?+\2Z7^P?\
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M ,0W_9U_^=S7S[9_LE?\$)=2_:*NOV2=(_8U_P""96M_M)Z9X&U'XDZ]\'=
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@12FE.E7G.4Y3G6IRO&K*<JM24I34G*52;;;G*_\ _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image00004.jpg
<TEXT>
begin 644 image00004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" &# B4# 2(  A$! Q$!_\0
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M: .LHKD_^$1N_P#H;_$O_?VW_P#C-'_"(W?_ $-_B7_O[;__ !F@#K**Y/\
MX1&[_P"AO\2_]_;?_P",T?\ "(W?_0X>)?\ O[;_ /QF@#K**Y/_ (1&[_Z'
M#Q+_ -_;?_XS1_PB-W_T.'B7_O[;_P#QF@#K**Y/_A$;O_H</$O_ ']M_P#X
MS1_PB-W_ -#AXE_[^V__ ,9H ZRBN3_X1&[_ .AP\2_]_;?_ .,T?\(C=_\
M0X>)?^_MO_\ &: .LHKD_P#A$;O_ *'#Q+_W]M__ (S1_P (C=_]#AXE_P"_
MMO\ _&: .LHKD_\ A$;O_H</$O\ W]M__C-'_"(W?_0X>)?^_MO_ /&: .LH
MKD_^$1N_^AP\2_\ ?VW_ /C-'_"(W?\ T.'B7_O[;_\ QF@#K**Y/_A$;O\
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M/_A$;O\ Z'#Q+_W]M_\ XS1_PB-W_P!#AXE_[^V__P 9H ZRBN3_ .$1N_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#XF_Z'"7_P %T/\ A7644 <G_8/B;_H<)?\ P70_X4?V#XF_Z'"7_P %T/\
MA7644 <G_8/B;_H<)?\ P70_X4?V#XF_Z'"7_P %T/\ A7644 <G_8/B;_H<
M)?\ P70_X4?V#XF_Z'"7_P %T/\ A7644 <G_8/B;_H<)?\ P70_X4?V#XF_
MZ'"7_P %T/\ A7644 <G_8/B;_H<)?\ P70_X4?V#XF_Z'"7_P %T/\ A764
M4 <G_8/B;_H<)?\ P70_X4?V#XF_Z'"7_P %T/\ A7644 <G_8/B;_H<)?\
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M^T+/_G[M_P#OX/\ &MP+-!Z56_M"S_Y^[?\ [^#_ !I&U"SVG_2[?_OX/\:
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M*K?;[/\ Y^[?_OX/\:/M]G_S]V__ '\'^- %FN3^+'_)./$/_7H]=']OL_\
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MBDT]2;'.^%O#?A;5ENYW\*Z+&H<!4:PBX&T<_=K>_P"$&\)?]"OH7_@OB_\
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M^+_XFNCHKH&<Y_P@OA+_ *%?0O\ P7Q?_$T?\(+X2_Z%?0O_  7Q?_$UT=%
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MHW_@Z?\ ^1Z .LI#TKE/[3\:?]"SHW_@Z?\ ^1Z/[3\:?]"SHW_@Z?\ ^1Z
M-3Q*LB:7)<P?ZZV(F7)Q]WJ/Q&165I-U-?3V5EJ&'N8TEFF]"0Y11^1;\A22
M7_C&1"DGA?1F1A@@ZTYS_P"2]4;=/%-OJ4E_'X<TJ2XG7#9U=U$?;:/W!SG
M;/OCMD\TZ;Y[IZ"MJ=+9Z3#%8M:S1I)#YC,H(Z G(KGUDN=-U#5#' 2;B91&
MO=@>,BK1U+QF5_Y%G1__  =/_P#(]9LK>)Y]6BN7T+3$NH4RMN-4<I(,]2_D
MC!![;315I*R41V-J/P\&T:.TG$1G+ S2J,%UW9;G&>E9[Z6WAR:VNXY9I+99
M6$R@'."ORC XP#W]ZL?VEXS[^&='_P#!T_\ \CTG]H>,F!#>&-&/KG6G.?\
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M^A9T;_P=/_\ (]']I^-/^A9T;_P=/_\ (],#K*0URG]I^-/^A9T;_P '3_\
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MZ%G1O_!T_P#\CT?VGXT_Z%G1O_!T_P#\CT =917)_P!I^-/^A9T;_P '3_\
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M44 %%%% !1110 4444 %%%(: (KK_CWD &25.*XKX;VKAKRY=2%.(QGKGO\
MTKNC6!X/&+?4,_\ /[+C\ZY:M/FJQ8FM;F^*6BBNH84444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7)_
M%C_DG'B'_KT>NLKD_BQ_R3CQ#_UZ/0!U@Z44#I10 4444 %%%% ')_%3_D1=
M0_WH?_1R5UE<G\5/^1%U#_>A_P#1R5UE !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -:HK*!+:$QQ_
M=W,WXDD_UJ>BE;6X!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD_BQ_R3CQ#_P!>CUUE<G\6
M/^2<>(?^O1Z .L'2B@=** "JFI72V=N96CFE[!(EW,Q] *MUF^()+Z+3W;2H
M!/=<!4+A?J<GTH H_P#"16WV&.X2&Z=Y)3$+=8_WN\=1MSV )Z]JT=&U"+4K
M4RPAU"NT;(ZX9&4X((]:YJ#3]0BM]-NHK!_M%K/([P23)NEWH07W XZMT]JV
MO#UM<V]M<27:+'-<SO/Y88'9N/ )'!.* ,WXJ?\ (BZA_O0_^CDKK*\S^*GA
M/1)?#>IZC)8[[MWB8R>:_.94!XW8[UO+\/O"Y8YTP?\ @1+_ /%4 ==17)_\
M*\\+_P#0+_\ (\O_ ,51_P *\\+_ /0+_P#(\O\ \50!UE%<G_PKSPO_ - O
M_P CR_\ Q5'_  KSPO\ ] O_ ,CR_P#Q5 '645R?_"O/"_\ T"__ "/+_P#%
M4?\ "O/"_P#T"_\ R/+_ /%4 =917)_\*\\+_P#0+_\ (\O_ ,51_P *\\+_
M /0+_P#(\O\ \50!UE%<G_PKSPO_ - O_P CR_\ Q5'_  KSPO\ ] O_ ,CR
M_P#Q5 '645R?_"O/"_\ T"__ "/+_P#%4?\ "O/"_P#T"_\ R/+_ /%4 =91
M7)_\*\\+_P#0+_\ (\O_ ,51_P *\\+_ /0+_P#(\O\ \50!UE%<G_PKSPO_
M - O_P CR_\ Q5'_  KSPO\ ] O_ ,CR_P#Q5 '645R?_"O/"_\ T"__ "/+
M_P#%4?\ "O/"_P#T"_\ R/+_ /%4 =917)_\*\\+_P#0+_\ (\O_ ,51_P *
M\\+_ /0+_P#(\O\ \50!UE%<G_PKSPO_ - O_P CR_\ Q5'_  KSPO\ ] O_
M ,CR_P#Q5 '645R?_"O/"_\ T"__ "/+_P#%4?\ "O/"_P#T"_\ R/+_ /%4
M =917)_\*\\+_P#0+_\ (\O_ ,51_P *\\+_ /0+_P#(\O\ \50!UE%<G_PK
MSPO_ - O_P CR_\ Q5'_  KSPO\ ] O_ ,CR_P#Q5 '645R?_"O/"_\ T"__
M "/+_P#%4?\ "O/"_P#T"_\ R/+_ /%4 =917)_\*\\+_P#0+_\ (\O_ ,51
M_P *\\+_ /0+_P#(\O\ \50!UE%<G_PKSPO_ - O_P CR_\ Q5'_  KSPO\
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MCDKK* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N3^+'_)./$/\
MUZ/765R?Q8_Y)QXA_P"O1Z .L'2B@=** "BBB@ HHHH Y/XJ?\B+J'^]#_Z.
M2NLKD_BI_P B+J'^]#_Z.2NLH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *Y/XL?\DX\0_\ 7H]=97)_%C_DG'B'_KT>@#K!THH'2B@ JKJ8G:SE
M%K,(9=I(D*[L?A5JH+ZTBO;=H)_,\MNOERM&W_?2D$?G0!RT=[>7>G^'[7[;
M/%)>%C+<1[=Y"JQP." 20.U:GANXN6MKJ&ZN#<O;W+P+,0 S =-V.,]C3T\,
MZ6E@EF([GR4?S$)O)C(C>JR%]R]QP1U-7]/T^VTZU6WLX]D2DG!8L23R2222
M23U).30!Y]\5O%%JGAO4M/:RUII5DB&]-+N&B.)4/$@3:>GK6\OCJP[Z9XD_
M#0KS_P"-T?%( >!M0P/XH?\ T<E=9@9Z"@#E/^$[T_\ Z!GB7_P0WG_QNC_A
M.M/_ .@9XE_\$-Y_\;KK,#THP/2@#D_^$ZT__H&>)?\ P0WG_P ;H_X3K3_^
M@9XE_P#!#>?_ !NNLP/2C ]* .3_ .$[T_\ Z!GB7_P0WG_QNC_A.]/_ .@9
MXE_\$-Y_\;KK,#THP/2@#D_^$[T__H&>)?\ P0WG_P ;H_X3O3_^@9XE_P#!
M#>?_ !NNLP/2C ]* .3_ .$[T_\ Z!GB7_P0WG_QNC_A.]/_ .@9XE_\$-Y_
M\;KK,#THP/2@#D_^$[T__H&>)?\ P0WG_P ;H_X3O3_^@9XE_P#!#>?_ !NN
MLP/2C ]* .3_ .$[T_\ Z!GB7_P0WG_QNC_A.]/_ .@9XE_\$-Y_\;KK,#TH
MP/2@#D_^$[T__H&>)?\ P0WG_P ;H_X3O3_^@9XE_P#!#>?_ !NNLP/2C ]*
M .3_ .$[T_\ Z!GB7_P0WG_QNC_A.]/_ .@9XE_\$-Y_\;KK,#THP/2@#D_^
M$[T__H&>)?\ P0WG_P ;H_X3O3_^@9XE_P#!#>?_ !NNLP/2C ]* .3_ .$[
MT_\ Z!GB7_P0WG_QNC_A.]/_ .@9XE_\$-Y_\;KK,#THP/2@#D_^$[T__H&>
M)?\ P0WG_P ;H_X3O3_^@9XE_P#!#>?_ !NNLP/2C ]* .3_ .$[T_\ Z!GB
M7_P0WG_QNC_A.]/_ .@9XE_\$-Y_\;KK,#THP/2@#D_^$[T__H&>)?\ P0WG
M_P ;H_X3O3_^@9XE_P#!#>?_ !NNLP/2C ]* .3_ .$[T_\ Z!GB7_P0WG_Q
MNC_A.]/_ .@9XE_\$-Y_\;KK,#THP/2@#D_^$[T__H&>)?\ P0WG_P ;H_X3
MO3_^@9XE_P#!#>?_ !NNLP/2C ]* .3_ .$[T_\ Z!GB7_P0WG_QNC_A.]/_
M .@9XE_\$-Y_\;KK,#THP/2@#D_^$[T__H&>)?\ P0WG_P ;H_X3O3_^@9XE
M_P#!#>?_ !NNLP/2C ]* .3_ .$[T_\ Z!GB7_P0WG_QNC_A.]/_ .@9XE_\
M$-Y_\;KK,#THP/2@#D_^$[T[_H&>)?\ P0WG_P :H_X3O3O^@9XE_P#!#>?_
M !JNLP/2C ]* .3_ .$[T[_H&>)?_!#>?_&J/^$[T[_H&>)?_!#>?_&JZS ]
M*,#TH Y/_A.]._Z!GB7_ ,$-Y_\ &J/^$[T[_H&>)?\ P0WG_P :KK,#THP/
M2@#D_P#A.]._Z!GB7_P0WG_QJC_A.]._Z!GB7_P0WG_QJNLP/2C ]* .3_X3
MO3O^@9XE_P#!#>?_ !JC_A.]._Z!GB7_ ,$-Y_\ &JZS ]*,#TH Y/\ X3O3
MO^@9XE_\$-Y_\:H_X3O3O^@9XE_\$-Y_\:KK,#THP/2@#D_^$[T[_H&>)?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5R?Q8_Y)QXA_Z]'KK*Y/XL?\
MDX\0_P#7H] '6#I10.E% !1110 453U'4[/38U?4+NVM$9MJM/(J MZ DBK"
MRAT#H5*D9!!R"* .7^*G_(BZA_O0_P#HY*ZRN1^*))\#:@"/XH.@_P"FR5UB
ML23T_"@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<G\6/\ DG'B
M'_KT>NLKDOBP<?#GQ /6T>@#K1THI%.110 M(U+10!RVMS167B.WNM1B=[1K
M5XE98C( Y9>, $\@?3BKO@ZWD@\.V<4\;1$)Q&W55/13]!@?A6VRYI&(3\:
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MIOL-IEY)'F#KGRL<"-#_ ,"]Q7H#2A02> .I-(@5@'!!'4$'K0!S'_"-Z_\
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M=54_C6M_PC>O_P#0[:I_X!6?_P :KJD^[QTIP.: .2/AS7_^AVU3_P  K/\
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M$H8MQRJQD<]&['@<5)X5MGFOY)D5$BBE99HL9028_P!9$>V>]=<Q"#!(7<<
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MTST%=*1F@#% #0A]?RKF_%=L]C')K%JX\V%/WL#\I<J/X<=F]#73TUER1^M
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M.>,4HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
9HH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image00005.jpg
<TEXT>
begin 644 image00005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" #/ 8\# 2(  A$! Q$!_\0
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MS7J1*Q ;(8%#\N"#C\,TVS\ "QO;+[#JUS#I=NT$ALO+4B22+HQ<\\X&1TH
MW=0\2:;87:VUW,4G:YCM%7:>9)%W+^! //M7)ZC\1A'ISWNFP175ON?RV8LA
MVA8F&01U/F9XXZ5J>+? 4'B+57OS?W-I*UH;=1$!\D@.4F'^VH+ >S&H;[X=
MV4]E-:PW4D$#N65$080%(D"_@(A^9I ;.M>+=*T2ZD@U%Y8O*MC=2.(F*1IG
M'+#@$G@#O5$?$#1&L8;F,7\@>1XWBCLY&D@*8WF1 ,H!N7)/J*G\3>#[/Q$F
MHQZA(YAO;5;5E Z;6+!OKDC@\<5C:7\.Y-*TVT@TK6I+*YC=S/<06<2>?&^W
M<FP#:I^1<,,D>],#3?QSH\EUJ-G:7#/=V<4TF9(V$<AC^^%;'S%<C(7GFI9?
M&^C0QN6DN"R+,S(ENQ8>7*(F&WU+G '?M6+8_"[3;'6]6O[6?:E]%,B1FV0M
M"TOWV$F-Y[X!/&>]:.J>!-/U%/$&]V635@@W% PAV$,,*>""XWD'KGF@"U)X
MUTB'PV^M3?:HK2.86[H]N_G)(6"A#'C=G)'YBJ]W\0M!M;.UN+F2\C\]G!B:
MU?S(=C;6,BXR@!(!)]167<^ [BU\ IH.FWL8N/MD5RUU';QP8VRJQ8(HVY 7
MIWQ46L?"NTU>*RDO+]I=1BD=KBZEM8Y/M =@S#81M0_*H!'0"A;@=98>)K"^
M_M1K?[08=/SYLQA81M@9.QNCX'I69J_Q T/2YT@N&O)9Y/)*106SRLWFH[I@
M*#_#$Y]L<ULZ?H<-GIMW9;V>"X>1B!A=H?J!BN7T?X=M9:O%J5YK=U?W,9BP
M7B1!MCAEB4 #VF)^H]Z0%B]\>6L&H:)%:P37EMJLD*1311L=HD5V#-QP,+]>
MN:ZG4]2MM-6W:Z9A]HN([:/:N<NYP.G;/?M7)1^ %M[72$L]4EBFTPV_ER>4
M&#B)77!'^T)#].,5H:QX9N]:TC1X[[5'AU*PF2Y:YMXAM>15(/R'C')QZ'%,
M2N9M]\5?"]BS^?/>%8Q*\C1V<CA$CE\IG) X4/D9K7\1>+++1KS1H98KB6/4
M68B>.,F.*)4+M([= H&,Y['/:N#T_P"#VVYN;2[U6Y;26M$LY,!=]XAD>64/
MQ\N7;G'4"NS\5>![3Q#/8^;=30V4%I/8O:1@;)(94",N>JG 7##T([F@9<\+
M>+](\23RP:8]P)8XDN-L]N\)>)\A)%W ;E.UL$>E/TGQ7IVJ:S-I<"WD=W'&
MTH%Q;/$)45MC,A8?, Q /U%4O"/@^/0+B6ZGU"YU"^>WCLUGF55\JWC)*1JJ
MC'5B2>YYJEX-^'Z^&M7N=0.JS7D\UK]E!DB565=V[)/5FZ9)ZXH C7XK>&&N
MI8$FOGDC,ZC98RL)#!CS0A PV,\XK3N?'&D6^H65HXOF-X%\B5;20QN[(75
M^,;BHSBLC3OAC9V.GI;K?322)IUS8B8QJ&#3N6DEZ_>/ _"H-5^&/VGQ#!JU
MKKMU;-:R&:VC:%)1"WDF(8)[+PP7H"* +P^(%CJFGV=SX:_TPW%U;VX:9'1,
MRMEAG!.]45B1VP,XJ*X^+/A> ,9'U$(L3W <6,I#QH^QW4[>55NI]ZM:;X"M
M]+L8+33[Z=(H;V6_0NH=O-DA:,DD]?F=G^IQT%8?_"I+1[ 6LNK7#Q#3+?2Q
MNC'$<<@DD/7K(1\U '4IXVT:2ZCMXY9FD>[:S7$+8,BQ>:W..@7G/KQ69'\4
MO#C-&,ZDN]8) S6$H'ES-M1\[>%+'&?<4RX^'7F7E[.NM7*+,UV\""%,6\EP
MH5G!ZD@9 SV--F^&MO+>&9M2G\OS+ K%L&!%:<K%U^Z6^8^XH ]!7I2TB\#%
M+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !167KVM66A6/VS5
M)VM[4.J--L9E0L< L0#M7/5CP.IXJ2+5;.74Y;".X1[N*(321KSY:G[I8C@9
M[9ZX..E &A13=Z[=VY<'H<TZ@ HHHH *Q?&6L'0?"NJ:FOE[[6W>1-_W=V/E
MS[9Q6U6/XFT.W\0:<MC>O,L'G1S,(VQNV.&"G@Y&0,CTH \OUCXEZII;ZAI?
MVO2[O4UE MKBWA)B*B+S) 0T@&5XYW<[AQUJUHOQ/O;V\M+*YM(8KVXM8-1D
M2,EA;6ODB25F)ZY.57W//3GTQM&TPVRVYTVS,"L66/R$VACU(&,9JEI7A;3-
M.U#4KV.'S;B_PDAE 8+$!A8E&,",=E]SZT >3Z7\2O&%WI\MQ]ETIF.E0ZJB
M>6XV^;.R11?>Y+J!SQCT:M74OB+K]C-KU_+8VBZ-817BJK.OF!X"R!L>9DAG
M7&-JX#=?7U:/3;%$PEG;*"J(0(E'RKRHZ=%[>E-DTG399)Y)-/LWDG $K-"I
M,@[;CCGIWH \/O/%7C'7M0L= EO[#2KS^T;5)KB%&"D?9O/DBY<9P=J]>=W2
MNE\9^/M7TGQ7<66G1VCVEG-I]O*KQDO+)<.054AOEP@SR#SV[UZ9-I.G3DF;
M3[20EQ*2\*G+@8#=.N !FGOIUD\QE>SMFE+K(7,2DEE^ZV<=1V- 'BTGQ.UJ
M_P!#ENH380QZEI5Q>6XB!,FFE"JH)B3@ERX'\.TCN*U_'&LZOX;TKP3IT.JQ
M7%S+(SW,L<?-W%;Q&5MN7X+A O4YW_A7J"Z5IZ+<*EC:*MQ_K@(5 E_WN.?Q
MIS:?9.ENKVENRVY!A!B4B(CIMXXQ[4 >=?#OQWJ7B+7K6VNX[&6VO],&JI]D
M+$V09@JPR$Y#,<GD;>5/'>LR+Q_XENCK%Z(--LM*C@N)+=[EEWQ-%)L4.H<L
MVX@C[JX) YQ7K5I8VEGYGV2U@@\QMS^5&%W'U..IJ+^RM.\R63[!:>9*P>1O
M)7+L.02<<D>M 'F,/CW5;_1],O$NM*TG[?:-J2O?(S1QQJR)Y)(8$N6;)(^Z
M!C!ZU53XF^()-1UNYAT2WDTG2C=PS1^>HFW6ZDEQELX)'3:.&!SG@^M2Z;8R
MB(2V5LXB<R1[HE.QCR2.."?6G#3[,7,EP+2W%Q(NQY?*7<R^A.,D>U 'CZ?$
M/Q-:W%II>J)I%K>WT\IBOI'5H8HXHO,=65)&^;H!\PSG..,5%I&J:P?AGX1*
MZB++4=>U(32/-ND*1O(TQ0'<"!L&WKT.*]>_L72OLZV_]F6/D*V]8_LZ;0WJ
M!C&?>II=-L9;6.VEL[9[>/&R)HE*)CI@8P,4 > 6'Q0UK1([NZ%M%?V^H_:;
MZ&(DAH"UVMO&6<L1L)).!@ #KSFO1K?Q)XAC^&>MZMJ-E;MJUE#<- MM(K++
MM4[3@,P!SVW'IUYKMETK3D3:EA:*OE^5@0J!LSG;TZ9YQ5BVM8+6W6"V@BA@
M486.- J@>@ XH \&\-^)=&\.:*VIZ5XGO=:UN^M[2*YCFE>X@-W.<J<;@L9X
M8%0P  &:U+/XE:W=^'([DOI-K>Q6U[<.)5+"Y$$JQJ$ ;AG._@%L<8S7KG]D
MZ:+9[8:?9_9W;>\7DKM9LYR1C!/O65!X1TF'79M36UB,CQ)%'$8U\N$*S-E%
MQ\I)8DF@#S?4OBKJMOK%S);065S96^H/8MIRJ3=-LA\QWW9P IR.G..M6=.^
M(/B.6PLH]2M=-LY=6NU@L[XR*\,*F)I&$BJYY 7 ^89+#@8KT'PKX4TSP[:M
M'9QF61Y))6GG :4F1BS#=@'&36HNDZ<MM]G73[-;??YGE"%0N[^]C&,^] 'C
M]O>:KXA^ ^M:_'.\5_<3SZI#Y,K$!8I]P53G.TK%T]ZCE\6W::=<>+K&\Q-K
MO&FPSINCM[2!"78J71<NP8YST(QFO:H;2V@M1:P6\,=L%VB%$ 0#TP.,5%)I
M>GR6L5M)8VC6\0Q'$T*E$XQP,8'% 'AWA?X@ZIJWBJPOV-O;1:@MC;3++)F*
M-3;O<2LN2!G!C //7O6K;_$;Q->:AIMK8:?9R-(D-Y*\KK$LL$TI"*A9Q\P0
M9) ;)(&!FO65T;2U0(NFV00,'"B!<!@, ].H'&?2I#IM@6@8V5J6@&V$^4N8
MQZ+QQ^% %/P_<7%W;W%Q+>V5Y!).QMI+3E1%G 4G)RPP<D8'M6O45M;PVL"0
MVT,<,*#"QQJ%51[ 5+0 4444 %%%% !1110 449HH **** "BBB@ HHHH **
M9-*D*,\C*J*"Q9C@ #O6?_PD&C=]6T\?]O*?XT 7[B))X'BF17C<;65AD$'J
M#7D5SX0U.W^$4EAIEO,=0ENDGOH9?GENX4E :/)(#?NE50I(! QGDFO33X@T
M8_\ ,7T__P "4_QI/[?T;_H+Z=CT^TI_C2 \&N_"%]_8.GRR>&=7NK1;JZ>V
MTR6TMY8[?S%B"DVWFCRP2KD,KY3<V!\PQ]!Z0+A=)LQ>HL=T(4\Y$<N%?:-P
M#'DC.>3R:J?V]HW_ $%].QZ?:$_QIW_"0:-_T%]/_P# E/\ &F!J45F?\)!H
MW;5M/_\  E/\:\\L?CKX./BG4]!U6\&FW-G.T*3S,#!. ?O+(.!^.!Z$T >K
M45%9W,%Y:Q7-I-'/;RJ'CDC8,KJ>A!'453U;6M.TB.)]4O(+1)7$<;3.%#,>
M@% &C156>_MH!,9YHXQ!&)9=[@>6ASAF]!\K<^QHL;^VO[5;BQFCN(&)"R1L
M&!P2#R/0@B@"+6;B:UM/,M]@E:6*,%UW ;I%7D @]SWJQ;+.J 7$D<CY.6CC
M*#\B3_.J7B!A]@C+<?Z5;#_R,E/U#6=.TV:WCU"]M[:2X?9"LL@4R'T&?\\B
M@#1HK.N=;TVU^T_:;ZVB^R[?/WRJ/*W?=#<\$]O6K=O<Q7-O'/;NLL,BATD0
MY5E/0@^E $U%9FJ:]IFE31Q:C?6UM)(K.BRR!2RK@$@>@)&?J*O13I+"LL3*
M\;J&5E.0P/0@^E $M%0?:HC(8PZF0-M*YY!P#C\B/S%+]H42^6?OX+ 9YQZ_
MJ* )J*9OP"3P/6HX+N*?B%T?Y0_RG(P>A_&@">BHWG2.)I)&544;BQ. !]:H
MZ5KFF:N7_LR^M[K8%9O*D#84YP>.QP<&@#2HJ%+F-Y)(T96DCQO4')7/3/I3
M]_MWQ0!4U6Z:UCC\I/,FE<1QH3@%L$\^P )_"A-2LA.+62]M?M8(5HA*-V['
M3&<__KJ+4%\S5-+;)'ERN<>O[MA_6N0TVSU;3]8\4XMM2"7U\TULT/E>4RF"
M- Q)^8'>IH [\RH%W,P  R2>,"A9$<91U8>H.:\LU+0]?CAMH@FL76GR6JF\
MBCU!O->X,3#.XN#M#  KD+SG!&:L7&C^)?MJF+[=';6]G^XCCNMJB9?LVT$!
MN1\LPP>#SGJ,H#TMG55+,P55&22< "F)<0N(BDJ,)5W1D,#O&,Y'K7FW@>;5
M9_&U['?/J$\,=M.MT[S%K=Y3<?N]B9PA\H=,#CUY)@NO#NN16]P+2VEBBTUD
MT[35BD^;[*TJM+(N'4YV*B8W*?W9]:8'J*S1M(T:R(9% 9E!Y .<$CT.#^5/
M+#IFO)M'TSQ+I^MR7SV6J31/:?9@6N%:5]KW/EER7[*\?))(+#T)K3\$Z?XI
MAU]I=>EO'C.\'=(&BV87RP!O(W#&"0@;(8EB#0!Z/D56AU"SG#^1=0R["%;8
MX;!/8X[^U12179DG/FPO;O%M2#RRI#8[OGD'Z"O-K'0]5>&PB&C7,,%E!;1L
M)I8C,C17$;".*:,AGA"JY^?DX7C.12 ]6R*9%/#+GRY4? R=K XS7EGA/2?$
M]S<^1XC_ +4CM)3#+<'[88QYOEW'FA"DK.$W>1P" >H Y 7PYX;UR&V-A=C4
MHK!#&$"7S*W$4^[#A]V#(8SU]/0TPZ'JV0*@%W;E XGBV%_+#;QC=G&W/KGC
M'K7FO@6;5QKUI;:TVH'4HK8_;V:YW0Y\J+:-@; ;.[G'.&.2#5Z_\,7T6N7X
ML[8/IG[S5[1=P 74"A3:1Z$G?Z;LGCB@#OS-&)%C+J)&!95)Y('7CVR/SI^1
M7C<&@^*(]72YAAU1XK>&39)<W(,A9I+=F5-TCLH*QL,%NQ_O8J_H^G^+&UR*
MXU,ZG';?:2\49FWJD9N92P?$NW_5E>JOQ@#:10!Z%)<7$EY/:1O%%.H$J.R%
M@\9XZ!AR#QU]/7B?1YII[/=<E#*LDD;&-2JG8[+D DG^'U[U7EC)\26;[F&+
M292OK\T?-2:"P:QD(Z?:KC_T<] &E1110 4444 %%%% ''_&$9^%/C#'_0(N
MO_134EA\//!CV-NY\*Z(2T:DDV4?/'TI_P 7_P#DE7C#_L$77_HIJZ32B&TN
MS(Z&%/\ T$4 <_\ \*Y\%_\ 0J:'_P" ,?\ A1_PKGP7_P!"IH?_ ( Q_P"%
M=510!RO_  KGP7_T*FA_^ ,?^%'_  KGP7_T*FA_^ ,?^%=510!RC?#GP7CG
MPGH1^MC&?Z5YG;_LY>&KGQ9J>KZV[RVUQ<-);Z9:?N(88R>%)7D_A@5[O10!
M2T72[+1=*MM.TJVCM;&V39%#&,*HKC_BE8:C>6=B=*LY;F99E'[HH=N98F^9
M7X*?(=W<<=LUWM&* .(USP[-+)KD]E;@3WD-F[,K &=X979DR3W7:HS@?-VY
MQI>'K2]CTF_8QFPN+J[FN(XVVR&,,W&0#C) R<'JW6NDP/04N!Z4 <K!#>V7
MA'3HM6F\ZZ2:T61MF,'S8QC@GOWS6'\1M)U6[UK3+K2+!+J1(980[,K*C'D"
M5'^4QDC)(^88XZUV/B-0VGQ*?^?JV./I/'6H,=J$.YYAJ7A?4(/%&H:G::>'
M@&I66H>7&Z!KHI'(DAY/W@64C<1G: *Z/3--U2T\*V5M;N8;[S7E8LPQ"'=G
MVD<AMH8+@'''!KK<#T%&!Z4".,NM'OKOQ3HUV6GMH(=+N+::5)(W99'> A#N
M!SD(_(';WKC_ !#X:\16EU]D\-0ZE%:PP-:0O%>K'&L LV5!@ON+^;MY 7&,
MY->QXHP#U% 'EVK^&=7LUU&'PU#>0^;.LI<WQ/FQB*-2@9F+!OED&2.,J<]P
MSQ#8ZOYVB-:V&L?V4JM%-:17Y,HW7$94,P?^X&).[&/ES7JF*, = * /(9M&
M\5RZY88MKY=.62-%'VU0([5C()$E^<EG"E!D GN&)&#(VA>((FCC^Q:E)I\>
MGVL,5M#?!#'.D3C=]\<*V,\\Y!^;;7K6*3 ]!0!YG9:'XD37+R>Y>YFCF%W%
M)NN,QLIAA$6U"QVC>)<<9Y.< BJC>'=;M"0UK>7!DTRSMFN(IHTDB6-\RP@*
MR L,[@V<$;@3P WK& >HHP/04 >*Z;X;\2QZ9.=0L]3%S+*#-MNT>26)!,L2
MEO-4$J/*R<@'.3D@@=QKEAX@N?!=G9Z?=O;ZZL<0:[DE!$;A?G9\ !LX8=.K
M XXX[' ]!2X ["@#G;8O$/#<<D$L#E2K12R>8\9$)R"V3N(]<G-:4EC,\C,-
M3O$!)(55APOL,H3^=0ZRH2_TF=^(TG96/8;HV S^/'XUK#I0!F#3IP,?VK?8
MZ8V0?_&Z#IUP2"=6OLCOMA_^-UIT4 9O]G7'_06OO^^(?_C=94E]9QW,T,OB
M.57A#&3=Y("A02XSY>,@<GTP<]*Z>O//%'AB_P!7TW4K*"V,)N/MBD-/OMY!
M(D@1@K$E'W,A. !]_J#0!UJ6<TB!H]8O&5AD$)"0<C@_ZNHK>/[0SK;ZW=2%
M'9&"+ =K#&0?W?&"1^=<+-X1UYX;P6QF@:>V: 1B=8XT EB,84K\^0@D!)8@
M=%&#FIH/!>HV<=_;V42P6]QJ+W!\N;:'B:YMWP<<_P"KCE4_7'<T =VMA/Q_
MQ-KWGG[D/_QNJLI2);EY=?N52U/[\GR?W>0#\W[OC@C\ZX";3=9LIM,TZ:"^
MN;[[5;M%-&TACMX%NY'?=)]W_5;1M)Y''IGK=:T2_G\3V\UFL3Z5>",:BLCX
M*F)MZ,JX^8M]QO8#KB@#6DMWA\L2:S>+YC!$XA&XXSC_ %?)P/TJ?[!<'KJ]
M\/\ @,/_ ,;KS3_A$/%MQJMW///M\^&X#'[20BRMYBQ%.K !&'+9/)'  %3W
MGA3Q3>6\ADNKJ%&=RL$-RF[=]G@1&+,"% >.0\ D;LCDT >B?V?<8_Y"U]_W
MS#_\;H_LZ?\ Z"U[_P!\0?\ QNKEC')#96\<[F25(U5W)R6(')S@9_(?2IZ
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M,313(LD3##(PX8>AJ5%VHJC/ QR<G\Z6B@ HHHH *2EHH !1110 A&:,4M%
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M'^9ST_PJ'06SF'*NK&^'S<G1;/[<9&N?+&]I%VN3ZL,G!Q[UH4SS$"L?,0A
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ME3Z'TJ2OESP,VJ6=E:&]U'Q+I]EKEY=7&MW$<<SW-M(F%@A+%,H63&7 RVT
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MI45858MA3N(.[:C-CN*[^O.[7X>6MYKWBO4/$H6Y35[E L<5S*JM:I$JK'*
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MQU(QWK=A\-Z9#?"]6)_M"7DM\',K']\Z&)FP3_<^4>G;%0W/@W0KK3;&QNK
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G7(+!20,=/7%=E426T*;-D2+L78I Q@>@]N!4M !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image00006.jpg
<TEXT>
begin 644 image00006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $, 3T# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZIHHI&;%
M QP/QIH<GM7$:]XS^S^,M/T>T>W$(<K>,SC<&*Y5 /7'/XUBV_B/Q,UI))#)
M'<R7MI)<VL,4 W0%7V[0/X^.>>] 'J6[I0IS^76O-O#OC*X?4K"RUZ[2T=0T
M<@FB"27$K-B-=H^Z0N"?=EKT=6QR>] $E%<K)\0?"\4C))J\*LIP1L<\_E3?
M^%B>%/\ H,0_]\/_ (4 =917)_\ "Q/"G_08A_[X?_"C_A8GA3_H,0_]\/\
MX4 =917)_P#"Q/"G_08A_P"^'_PH_P"%B>%/^@Q#_P!\/_A0!UE%<G_PL3PI
M_P!!B'_OA_\ "C_A8GA3_H,0_P#?#_X4 =917)_\+$\*?]!B'_OA_P#"C_A8
MGA3_ *#$/_?#_P"% '645R?_  L3PI_T&(?^^'_PH_X6)X4_Z#$/_?#_ .%
M'645R?\ PL3PI_T&(?\ OA_\*/\ A8GA3_H,0_\ ?#_X4 =917)_\+$\*?\
M08A_[X?_  H_X6)X4_Z#$/\ WP_^% '645R?_"Q/"G_08A_[X?\ PH_X6)X4
M_P"@Q#_WP_\ A0!UE%<G_P +$\*?]!B'_OA_\*/^%B>%/^@Q#_WP_P#A0!UE
M%<G_ ,+$\*?]!B'_ +X?_"C_ (6)X4_Z#$/_ 'P_^% '645R?_"Q/"G_ $&(
M?^^'_P */^%B>%/^@Q#_ -\/_A0!UE%<G_PL3PI_T&(?^^'_ ,*/^%B>%/\
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MWP@NC:@US_:$]RJ1M#;12* ($9MQ (Y;GN: ,KPSXTFU.\L;:_:RM7*-Y[R
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M,0D&!*TA+,I4R,=A+%F7/2O5\8/YT 9WA;_D7=-_ZX+_ "K4K+\+?\B[IO\
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M[*'3K&"TLH4AMX(UCCC7HJJ, ?D *MCI6@Q%&%Q2T44 %%%% !1110 4444
M%<G=?\E6TS_L"W?_ */MJZRN3NO^2K:9_P!@6[_]'VU '64444 >:?%8^(8#
M:WEI'H;Z):GSII+PN)HY!P-O[V-6!S@AF48)'.<5:^"AAD\,7$L!B)>Y8.41
MP<JJJ!N:64. % !5RH "\;<!OCC0/"FH>(-/N]?U66RU$*8K<+?F $$$GY<X
M/ /)KH/!,.E6UG=6VB:E+J$,,VV1I+DS['*JVT-T P0<#UH Z.BBL./Q;H4G
MV[9J<!^P@FXZ_(!WZ<_AF@#<H/2LRQU[2[\6AL[R.7[6&:$#.7"_>X[8]ZTB
M1ZT 9GA;_D7=-_ZX+_*M2LKPM_R+NF_]<%_E6K0 4444 %%%% !1110 4444
M %%%% !1110 449J*21(U+,P 4$DT 97B?4_[,T\M&-US*WE0(.K,:R+>XM?
M"FEQ"],ES?7,@+I"N^1F8XW;1SM'<]JP$U>\\0>);V?2+5;A[.(K9R2_\>ZN
M&&X.0<[B#D>U=;HOAU+.9;V]D>^U(;]ES,=SQ(YR8U/]T=JQA[SYV2M7<ATO
M0KJ[N&O_ !*(KBXWJT5J")(("A.UX\@$/C&374*"%&<9]J%^Z,TM;%!1110
M4444 %%%% !1110 4444 %<G=?\ )5M,_P"P+=_^C[:NL)QUKDKDY^*VF?\
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M9;_^"E?_ (Y6QX6_Y%W3?^N"_P JU* .3_L;Q9_T-EO_ ."E?_CE']C>+/\
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M444 %%%% !7)W7_)5M,_[ MW_P"C[:NLKD[K_DJVF?\ 8%N__1]M0!UE%%%
M'DGQ@O+J[%Q;VR+%;Z3''=W-PN7E59=\7[N/HQV>9P2.V.:ZCX7Z9JMAI-]/
MKP OKVZ,YX ;8$6--RC(4[8UX!/OSFH?%_A*PU*\GO+S7-1TU;M(K62.WEB1
M)BK,4'SHW.7/0BMGP4UI+I3S:?X@EU^VDD)%V\T4O(P"H,:JN 1]<DT =!10
M2!U(HR/44 %!Z49%!Z4 9?A;_D7=-_ZX+_*M2LOPM_R+NF_]<%_E6I0 4444
M %%%% !110>AH ;VJO=W,-K TMPZQQH/F9CC%5]8U6UTFT:>[D"J!P,\L?0>
M]<W;V%[XEN$N]75[?3AS%: X9_=ZQE4MI'5B;Z$4EW?^+6\BQ22STL,1)<'[
MSX/\/L<5T^CZ5:Z3;F&RCV*6W,<Y+'U)J[!#'!$L<2A$48"@8 J6G"GKS2W$
MH]6.HHHK4H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD[K_DJ
MVF?]@6[_ /1]M765R=U_R5;3/^P+=_\ H^VH ZRBBB@#S_XS[%\-P2"XFANT
ME80"& 3,Q:)U<A2Z#(1G;)88QGGH9?!2Q:7INMM90W%W-#=A39Q1K&R*L,2Q
M*H9]IS$(SN+#.XY ^Z,[XP74\=G9076C)>Z5)+B6X6\:WEB;:V-A4%LGIQG@
MD8YR-/X1LDF@W<L4"11O<G:3=/<3/A$!,KN =V00!@84+0!S/CB\\-ZMJ%M!
MJ-K:6'B66)&235YHEDL$#9#(-Y4.3TV'/.3V!R_"VC66L1RZ?IES&EY=:?(-
M6E(WEI?,^4SC(W,1ZG)7VKVV6UMY7WRP1._]YD!-/CABC9C'&BEOO%5 S]:
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MR3-RS'O^'M6T  1Q4*+EK,7+U8NT>@_*EQ116Q04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R=U_R5;3/^P+=_\
MH^VKK*Y.Z_Y*MIG_ &!;O_T?;4 =91110 5%<2K#'OD=40=68X ^M2U%=VT%
MY;O!=PQSP.,-'(H96'H0>M '$>-O&ZZ1-86VF3VDLLDB/,S2 A(2<9]R3G'T
MK(A\3^)I;.:6%XKF6]M)+FTBA@!,)5]NW_;XYY[UU^J>"?#NH0P12Z/8(L+!
MD\NV0;<'./N\#VIN@^$;#0[V6YM)KJ3<ICBCED!2W0G)1  ,#/KF@#G/#OC2
MYEU&PL=<NXK-PK))Y\?ER7$K-B-0O\)VX8^Y4=Z]$9^W/K7*7'@;39YK65I;
MM'BD:20JZYGRZOB0D<@%5Z8/RBNK8JI4,0"QP >,T >67VI:JUM9:5=:5K$5
MA%&HD:UM&E:3';*]*Z#3O$UCI]LD%KX<\1I&HQQIDG-;=CXBL+S5Y-.C,PN$
MW89H76-\==CD8;'?%;:@5"@KW9*6IRO_  FL/_0 \2_^"R2C_A-8O^@!XE_\
M%DE=6QPN:A:4*VUBH;!.#Z<591S7_";1?] #Q+_X+)*/^$VB_P"@!XE_\%DE
M:.A>(K'69Y8K0SAXP&Q- T6]3T9=P&Y>.HR*V\4 <G_PFT7_ $ /$O\ X+)*
M/^$VB_Z 'B7_ ,%DE=8>E0O*$;#D D9% ',_\)M%_P! #Q+_ ."R2C_A-HO^
M@!XE_P#!9)6CH7B*RUF6:*T^T))$02L\#Q;U/1EW ;A[CBMO% ')_P#";1?]
M #Q+_P""R2C_ (3:+_H >)?_  625UE4KV^BL[6:>X<+'"AD?') '/3J>E &
M!_PFT7_0 \2_^"R2C_A-HO\ H >)?_!9)6KH.MVVM6\DMH)U\MMKQW$+12*<
M9Y5@".""/K6O0!R?_";1?] #Q+_X+)*/^$VB_P"@!XE_\%DE=9BJE]>0V=K/
M<7#[(H49W(7. .3TH Y[_A-HO^@!XE_\%DE'_";1?] #Q+_X+)*UM#UJVUJ%
MY+07">6^QX[FW>"13@'E' 8<$'ISD5JCI0!RG_";1?\ 0 \2_P#@LDH_X3:+
M_H >)?\ P625UF*Q=8UV&RM;I[8?;;B"5(3;02(',C;<*=Q !^93R1P: ,W_
M (3:+_H >)?_  624?\ ";1?] #Q+_X+)*VM U1=8TU+I8)+=]SH\,A4M&RL
M5925)!P0>02*TJ .3_X3:+_H >)?_!9)1_PFT7_0 \2_^"R2NH?(;/;'I61J
MFOV]G:W$EL/MUQ#(L1MH)$WEV( 7YB #\P/)% &=_P )M%_T /$O_@LDH_X3
M:+_H >)?_!9)6WX?U-=7TU+H0O ^]XY(9,%HW5BK*2"0<$'D$CT)K1Q0!R?_
M  FT7_0 \2_^"R2C_A-HO^@!XE_\%DE=4W'M7/ZMXECM+>*33K=]4DEE:)8[
M:6(?,H.X$NP QM/?MCK0!5_X3:+_ * 'B7_P624?\)M%_P! #Q+_ ."R2N@T
MB^BU/3K:\@SY5Q$LR;ASM89&?SJYB@#DF\;18XT'Q+_X+)*IZ3>S:U\1+6_C
MTO5+2TM]*N('DO+5H07>:!E49Z\(Q_"NUG=8HR[D*B\LQZ >]<SK'BZWT^&"
M:UMY;^V>(W$DUK)'LBB&,O\ ,PW#GHN3[4 =513(F+#)_P#U4^@ HHHH " >
MM)M Z4M% ";17(?$X.?#JA(^LZYN!#)*UOP?G"QLKD]%^5A][TR*[ UP?QAF
MMK;PS;W%^T+6D5W&TMO,6$=P.1L8J#@9(/3&0!WH J?#OP[>V%U%J-W>-J(N
M8B^^X:19(2W)VIG8 WLJD8YR:]&%>+_#/4;#4?&SIH^D6^BK;PL)E@#D7.<$
M$DHHX]^>:]H'6@ 8\?IUQ7G?Q62<PV M=ULY+[;V*VEG>-\#:@$9!&[DY;*_
M+R#FO1'^[S7E_P 99X[:;1KB;21KEO$)FETXL%&W"YF.0?N=.G\= &W\/O#U
MSH4EQ]IF%WYJ*5GDE=I5_P!@AB5 [_(%'/2NVKROX13//JU_(N@_\(U"T"%=
M-+!M_)_?#  P>GK\M>J4 (WW37G?Q76X,-A]ES:RG<%OXK:6:1'&-J!8R.&^
M;ER5XY!!->BGH:\N^+S,FH:%MT5O$1 F_P")2K!=PPN9<GCY>!_P,T ;?P_\
M.W&@^=Y\ZWB2JI2XDE=Y5']P@L5&.N4VKSPHKMJ\O^&3Q#Q!>"WTZVTBWDM8
MI19V[[T+%F!<G PW&W&/X17J% !7EGQ)M;F\\16MM:RSZ>T\:Q?:;6WD=[@,
MQ#(74^6H4<YD5N6R,$9KU.O+/B!:6A\41W6HVNC:E$UJ(X[74;Q8#"=Y)900
M<AA@'_=H ZOP1HT^B:?-;73QW$I?<;D22.TPP,%O,9R,=/O'@=NE=17#_#.W
M2#3[]K?[!%:27&Z*SLK@31VPVC*AA@<G)Z#K7<4 %>6?$JPNK[Q):VUFUQ8/
M/&D1NK.SFDEN59R'0R*?*C"J209D<?.2NUAFO4Z\\\9^&9M1\2B_FT#3_$%F
M;80I!>3B,6[!B2R@JP.X$>GW?>@#;\%Z--H.F2VUV89I#+N^TK),[3# P7\Y
MW8$?= +D84$8SM'4+T%<AX!T>YT>UOEGL;73H)[CS8+"V?S([==BJ0&P.I4M
MT'WJZ]>G- !7B?CZ'2=1^(#6OBC4H+*+:H1WN;*&+R-N1YF_]\["09V,&B.%
MRIYKVRO-M:_XE7B35'L]>\+P?;)$EEAU0;I8WV!< B1<+@*<$=S0!U_@^U@L
M_#=C!975I=V:1X@GM8TC1X_X2!'\F<8R5 4G) 4' VJY_P #6L=IX?C6*^M[
M_P R6:=YK<CRB[R,[!,$X4%B ,G@<UT% #6^]7BOCZ#2=0\>-;>*-2ALHBH"
ML]U911&#;D;PW[Z1M^3L8-$=JY4\U[4WWJ\IU.]O=.\9:NNE?8VM)IHVNKJ]
ML&FCMI2@ 0NLBD#&T_=(&[)(% '?^#[:*S\-V-O:W5K>6D<86WGMHTCCDB_@
M("?)G;C)4!2<D!1P-FN8^'21Q^'71)O/=;VZ69PFQ?-$[[P@R<(&W!><[0*Z
M>@!K]1[UX-JEEX>U;QEJ<7BO6K2QN%9M[37.G+"&!'E[8B&:1@F0?M"MMRVS
M'!KWB0X(Z?C7BK:WJ6FWMYINAV\.H027$\L3R:6TKN-Q,A#B900C';R >@&:
M /8=*22*Q@29X7=8U#&&/RXR<<E5R=J^@R<>IJY6+X,AM[;PGH\%C<M=VD5G
M"D-PW69 @PY^O6MJ@"&[W_9Y#%M\P*2N[IG'%>#^']/\/ZKKDDU[K>GVVMQW
M"M#%>RZ?,CW.[Y@EO'D;2P'S?+,< ;QS7NVHJDEE,DK%49&!8=0,=17A,GB"
MSET6/08M<TN33;C-@+B#1[DSJH!R2^=N_ /('7M0![U$23SCIV^M25'$ .F3
MQC)[U)0 4444 %%%% !4%[:P7=L\-U$DT+<,CC(-3T$9ZT <IX.T6'2=2UH0
M6<EO$TZB,M(6#*$&"N>@KJZ0* <BEH #TYK,U'1K2^O+.[G5O.M=XC(.,JXP
MRGU!P./85I]:",T <_X:MFDGN]3O+9H+Z5VA*LV0(T8A=OH#U_&N@HQ10 'I
M6=>:3;W=_9WK[UN;0MY;JV,AA@@^H.!Q["M&@]#0!R_AG2HFU*\UR>R:TU&Y
M)@D3=E61';8V/<<_C745Q3>/;&*PN+I[2[Q!J1TOR\+DOOV[AS]WO]*VQXET
MG^T9K ZE9"^A0R20&9=Z*.22N<@8H VJP-=\.Z;J-Y;ZE=64=Q>V:.(MR@[@
MPY4^H[_6H+?QKHEU>&*UO[::!86F:Y253$H#*""<]?F%-U?QMH.EV^JO+J=H
M\VEQ&:YMXYE,B 8 !7/!)8 9[D4 :'AV%4TBWD-A%8331K)-!&H 5B.1QWK8
MKGM;\36FE>&_[;57N[+$; VY5BZN0 PYP1S38/%EG)KEYISJ\(M;5+N2XDP(
MPK=LYSD=^U '1TTH#GWK";Q?H TE=4.LZ=_9S-Y:W/VA?++?W=V>M2R>)]&2
M^L[)]4LEN[Q ]M"9AOE4]"H[@T ;.T4O2LQ]<TY(S(;ZU"8D.XRC'[LXD_[Y
MZ'TJE_PF/A_9;O\ VUIP2Y<QPDW"XD8<$+SR<T =!6+/X7T>?7'U>>Q@DO)(
M1"[.@8.H.1D$=1V/N:CO?$L%GXBM](EAE,DUM)<B48V )U!YSFJ>F^.M%N=%
ML=3O+N+38KV1XH$O)%1G96*X SU.,X]Q0!TMM;PVL(BMH8X8EZ)&H4#\!4M4
M&U6S&[_2H,)*(6RXX<]%^OM5)/%FA/\ ;=FL6!%D<7)\]?W)Z?-SQS0!N8S6
M=;Z-:07M]<(K'[;CSHRV48@8W;?4C /L!5"Q\8>'[Z0I::UITSA#(5CN%8[1
MU;KT%(?&?AT:6NIG6]._L]I/*%S]H7RR^,[=V<9Q0!>\.Z)9^'M,%AIJNML)
M9)0KMN(+N7//IECBM.L&P\5:7J&O2Z19W4,UU':Q7?R."&23.TCGG@ _1AZU
MNJV<T !4$\UD6WAZSM;6]@M6GA6Z=Y"R28:(O][8?X<GGZUL44 06-I#86<%
MK:H(X(8UBC0=%51@#\JGHHH 1E##!K"D\)Z2VMVVJQPO#=PR&3]TY5';:5RR
M]#PQ_.MZB@!%4#IZ8I:** "BBB@ HHHH **** "BBB@ HHHH **** "@]#11
M0!Y?)X"U)KF607%KY+3R7'E[C@N;CS%8Y'!"';5.7P+K\_BF2\=[/[.'N<.+
MZ7+K*N%_<!!&A'<\D]R:]96, YYS2L@88R0/:@#SF]\&:C]OT*^LI+99])LE
MA2-I&\J1PR9!&,8(#8;&0<'%9$?PYU)?[8@$=JWFV]ZEM=2:C=2%VG)8 P$^
M7"HS@E=V< @"O7%C [L><\FE" #&30!S?B#2KK6_#*6,J6\=TS0M+&)"Z+M=
M68!MH)& 0#@9]JY&7X?ZC<:=J,$]Y;M/<0&+S5=U)(DW*"5 (&,#(.17J0C&
M2>N>U-\H8ZMUSG- 'DL_@36SI<20VUE%*]R\D]N-8NR<&,JK?:F4RD@GHH0$
M<$D5$OP^\0PKH'V::RBGLX;2.XN5NY #Y!Z- Z/'+UW*W[MU.#NXKV'8,@CC
MZ=Z-@_+I[4 >6W'@WQ!<37-JYTT6"+J(@<3.7E-RVY=R%,(%Z'#-GVJ;Q1X'
MO]1U.RGMH[6: 6D=I)')J%S;)'M.=P6' E'^RVWZUZ;M%)L'&>2.YH X7Q7X
M2O\ 5-0AN-.N((&AM!;HS%LJ=ZDX&#P5!'7/-9E[X*U:*S$&FII<R2VEYITB
MW,C*L,4\NX.N$.\@  QG:#_>&*],:,$\YZ=*4IGH2.,<4 <0OA*X3Q+!<"=/
M[)2!7DB('F-=A/+$O3&/+X//4"N8TGX<7]O9SV\\5D2L201SMJ%U.9E$@8YC
MD.R$8'W5##/>O7B@)."1GKBC;D]30!YAKWP_O=5M;F"&>UM_.NKF?<K.#AX]
MJC( (/K@].AJQX;\&7MG>6%Y<V]G;RQ7K7$B+?W%ZQ!@>,'S9N2V6Z8  ]>M
M>C[![T;![_6@#A_!/AK4] N[47'V)[5-*M[)V21MR21L_P!T%>5(8<Y![8XS
@7<1C HV#\?7O3@,"@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000947263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">TORONTO DOMINION BANK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-283969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$5,951,030.00</span>. The prospectus is a final prospectus for the related offering.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 5,951,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>12</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 12,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 10,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001140361-25-040186-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-040186-xbrl.zip
M4$L#!!0    ( ). 8UO W&AV3P@  %X7   0    97AF:6QI;F=F965S+FAT
M;>U867/B2!)^[U]1H]U8SX1;EA"746-UF,O&!LSE<V(>A%2":G115>+PKY\L
M@4!@X^W>[GT;V]$M569E?GE7J?QUZ;EHCBDC@7]QDCE33Q#VK< F_OCBY')0
M;39/OAJ?RK_),KK"/J8FQS8:K5 U\,*!1="0FCYS NJAW[GW!Y+1A/-05Y3%
M8G%F 0^S",4LB*B%F5A LKP15Z58"--1@Q)T9W&4S:!,0<\7=*V [H=5I*E:
M?LN^AU,"G-(.IQ3CE+YN1?^_D XCC-HF16H.:5E=U70U<X!TP@$F0/69OI%Y
M(6WTO*=#VO#:>,>W'%'WC&'K;!S,%2 H0GK"Z#CV^XQ V&,D+,AIF>*665@9
M;PCH&!C5K++AV&Y8'N/- *_O$A\_5?JM'3M_GW_'JO#$XR:'J EXJJQJ<D9+
M"9'!@#U!B4$?R<GD9?5<SF82.< Y_<!201Z9#"?L$9/Y*L1LN\4QV2AF3RA[
MKA3"[(/X;&07E#4QS4H^\KG/N.E;6R1+]P/FIQ;@WG$>VKC(QJR94JFDQ-0M
M*WN/#T1FE*=V:V!-L&?*;Y P\N.[CN,1=2 9GQ J3[!IBP=XY(2[V$!E9?VP
M7A0%UB(6]AF4*P]T5*&!:5-BCS%J$!^T$=-%@\"-1/#99]3TK3-4"ZS(PSY'
MUKHV4<2@$Z3W=OMW#G$QTO)G&?C-:\42M()P1<EXPA&@A(I=%VYJDZAA^"E[
MF)O("GP.*BXDCI=<B2V*>X:,9Q&97TC5-5T>0L9("A2_LK:U/ KLE5&VR1PQ
MOG+QA>0 I^R8'G%7.KJD8- 7%*\Q\HIU5 KY%R24R*9+QKZ.7.S BA6X =41
M'8]^5S\C\??'%RF6NW%=2L-[O&A/[<F0>)BA#EZ@?N"9_LD>! _;)/*2)2%3
M1[ZHN 3IW 38\#\ -'D$3>P(W3+#0](""Y?K**>J7\ TSC&566A:$+ =9T##
M"52YCK1]5T"^T<0[Q+?!WSI2P^5F9=L9A" ??T$+8@>+M91%0.V=GG@/0!E-
M"6P3>QFGP13+L(-/-O3%A' <[TF9'S/;V IHW'YD/B'6U,<,M!"?</(>S\:#
M1^F;<&WIH6F+22:/ LX#,$83<*!^XCBO(VULGO?CGG85U!"X]B#L;[,-9/.#
MR(P"UP9U5=.U(C=&B ('JL\5-=7 & W-D8M96?G?<;Q)O\^(84J</6@9[1BT
M,@3%WRNGS0YAC&3\YU^9 B1761%L1GE$E13,GT#](]XKDZ4.2=B!OD2)M>X>
M2]['#E0GG%9\TQ/0'5MO0&(-0PD1&.5D.9>SFF0TY&Q9V1-@_./MG_8VG)[T
MN@_39M7'8\)$M^ =H*1\GY6,X5W_KC.\0[6[=K/3O.N@RF7G]I]HO(W&<8@=
MDXK.-L>H1ICE!@PFQ*_UV!&'_0KO[-X_SBG,8+@)]#3"Z7KN4,KG-3";T5UB
M:07)^!7NAO2<8.292^)%'C+'8XIA &/HSPZ A/8< E3QBCCPP>$YHC!3P'<\
M$./,FL3K(0U8B"T>,40Q='B@$X;V7/<]8\YQ Y,GH]8F+'3-E2"+DSKZC7AA
M0.%X*$#_>^/+!C6M>)X<.A,T$1BO<(2$V\#Z;"\<QW4_\F0[B*$(AC>.;IO+
MR_&8WVWL[X+Y$H+("!M ;@188R41LU-EGI.,_.=2/O-9S:IGJII4=P+/V.3'
M&1KN>PN\9/ZWO$BC=\@2V_)AAC1\MTM9:''6<,<I5'G)<."(ZZ8T'O8=(3T.
MX3IN]C;P9^OL?=.GXL7C32#ULGU,),7_IG)V&V$1\'7+%2=<3 V$/L5OQ(83
M6?+V7<,/;N,CR!:[N[4X/EMTS)1;SJ&A*)=O//&]:G9=OPJ%1DVW">?&Y2U>
MI524)$.%GU*NJ!7>3-X?, <.1_7EA(P(3T_TG"H9]2>YT6PU.U>H4:\/?D)%
MDNEO_)3+_)R?-L(9YF]%:^^+_G[!,'!].$#BSB@E%89M-IN5M?-LJ5!Z!_>/
M(!]$(X\PYN_Y'<H\I^4JVA'92CIGU[HH!N]BN-(RHRPNT3J+;[J@$,67:GU"
MA6YQ[V/'OKF(!UD\G"U%TUGO$]\1+B0&3=$5M\-8=TI9HGWS,>B=^_21+P=&
M.?[(H&\\DVQ<.P%<%-LJBGK-AN-",.*E[2(1]RCB$$Q1;"Y^]PM,M7F[7R6'
MF[>JE -=:/W=[,_']D/AKS]?^;U[U[HIE6X*U=*J/2T,SYOGE_WAZ4LQVY@6
MR7TG^]IAI:O7Z;-68/>55M!SG5>_$CK^2\'.YXHOF<5UKW(]>7SJ6HU.NVOG
MJF-'R_<[-Z^6W6NUJ-F=3W,/+Z.%Z]!%=E;+M&:=QX)S[]QXM>@:*ZO'VJC?
MK73;V8=7,KBO%*V9_4IF3Q9A=XUOSXOA,%^J#2>-7G9:[UW6E_0TE]%>'_R9
M56T6YR0?L5(OJA8]OQ!HE5/W!>/!5>]^>/K\,NNYA>O6Y?0F/ZL5!\]>+_?M
MFM@NKMU6>7-1][MN4 G54<Y_\;SQ78V'>>M;:]PFK[.B<O70R<QP9+X6"X\O
MI^.K06F^:&:=L/IPVJ\N*T^K7N@'9O-IL2SAV9!0_VF"L39MAC>M>N^965RY
M>2@\VU&AFKOBM4ZO]MBL6^/"1'OI?^/=5:-;F<W<B5)SG/O+\/)EJ%7LAVZU
M]OA\>UI8M.[;_=IUI]*_S;0GY^VGA?505Y06[=_<WH1J=M&T-)><#_]"U4%?
MEC<%M$V@$*HJL ^R*KZJUV!(&:(6Y(PJ9]4D-7:T1%(J0^TCFQ)*.L>VFD4Y
M[U5"4ACB!+!?%>(H8*3A>]@4)U1C\PE4OQ_4$F$)*>D8.YE)"6\J=OV:S,-/
MR0R-O_V(3T'<<XV_ 5!+ 0(4 Q0    ( ). 8UO W&AV3P@  %X7   0
M          "  0    !E>&9I;&EN9V9E97,N:'1M4$L%!@     !  $ /@
' 'T(      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000947263</identifier>
        </entity>
        <period>
            <startDate>2025-10-30</startDate>
            <endDate>2025-10-30</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <ffd:FormTp contextRef="c0" id="ixv-32">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-33">TORONTO DOMINION BANK</dei:EntityRegistrantName>
    <ffd:NrrtvDsclsr contextRef="c0" id="ixv-26">&lt;div style="text-align: center; font-family: Arial; font-size: 12pt;"&gt;The maximum aggregate offering price of the securities to which the prospectus relates is &lt;span style="text-decoration-thickness: initial; float: none; display: inline !important;"&gt;$5,951,030.00&lt;/span&gt;. The prospectus is a final prospectus for the related offering.&lt;/div&gt;</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtOfferingPric contextRef="c0" decimals="2" id="ixv-34" unitRef="usd">5951030</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c0" id="ixv-35">true</ffd:FnlPrspctsFlg>
    <ffd:CombinedProspectusTableNa contextRef="c0" id="ixv-38">N/A</ffd:CombinedProspectusTableNa>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-39">0000947263</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-40">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OfferingTableNa contextRef="c0" id="ixv-41">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="c0" id="ixv-42">N/A</ffd:OffsetTableNa>
    <ffd:RegnFileNb contextRef="c0" id="ixv-43">333-283969</ffd:RegnFileNb>
    <ffd:SubmissnTp contextRef="c0" id="ixv-44">424B2</ffd:SubmissnTp>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
